The Role of Mitochondrial ATP-Binding Cassette Transporter ABCB6 in Metabolism and Energy Balance by Tessman, Robert Thomas
                                                                                                                                                           
The Role of Mitochondrial ATP-Binding Cassette Transporter 
ABCB6 in Metabolism and Energy Balance 
By 
  © 2019 
Robert T Tessman 
Submitted to the graduate degree program in Toxicology and the Graduate Faculty of 
the University of Kansas in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy. 
 
               
 
Committee Chair: Partha Kasturi, PhD 
               
 
Bruno Hagenbuch, PhD 
               
 
Hao Zhu, PhD 
               
 
Tiangang Li, PhD 
               
 
Luciano DiTacchio, PhD 




The dissertation committee for Robert T Tessman certifies that this 
is the approved version of the following dissertation: 
The role of Mitochondrial ATP-Binding Cassette Transporter 




               
 



















      Obesity and the associated health risks represent a world-wide health and financial 
crisis. Lack of physical activity combined with excessive caloric intake are the root 
cause of the problem. Despite the increased advocation for healthy lifestyle choices, the 
trend has yet to reverse and indeed, seems to be on the rise especially among pre-
teens and adolescents, a constituent that had not been previously part of the obesity 
epidemic.  
     Mitochondria are the “fuel-burners” of the body and like other combustion devices, 
become inefficient in the context of fuel surplus. Moreover, with chronic over-feeding, 
the physiological mechanisms that regulate energy balance become permanently 
dysfunctional leading to the progression of pathologies such as Type II diabetes and 
cardiovascular disease. 
     Medical and scientific evidence confirms that mitochondria are integral to the 
responses necessary to adapt to over-nutrition. However, success in mitochondria-
based therapies has been extremely limited in the context of metabolic diseases. Our 
knowledge of the regulation of mitochondrial function, dynamics, signaling, and 
transport processes in different tissues and organ systems is extremely limited and this 
knowledge gap is a serious impediment to progress toward targeting mitochondria for 
treatment of metabolic diseases.  
     In this study, we successfully genetically manipulated the expression of 
mitochondrial transporter ABCB6. The physiological function of this transporter is 
unknown but non-functional mutations of this protein have been linked to several 
heritable human diseases. 
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     This study establishes that ABCB6 plays a role in the maintenance of energy 
homeostasis. Whole-body Abcb6 knockout adult male and female mice have increased 
body mass with no increases in food consumption. Increased body mass is due to 
increased adiposity. ABCB6 deficiency results in steatosis, glucose intolerance, insulin 
resistance, and lower energy expenditure. Exposure to high-fat diet exacerbates these 
metabolic derangements.  
     Genetically targeting ABCB6 expression specifically in liver results in disruption of 
whole-body energy metabolism as well with a loss of metabolic flexibility. Loss of 
hepatic ABCB6 results in fragmented mitochondria while overexpression leads to 
mitochondrial elongation, dysregulating dynamic mitochondrial functional responses to 
energy status. In this liver-specific model, hepatic metabolites are significantly altered 
with either ABCB6 knockdown or overexpression. Metabolites that have a profound 
impact on energy metabolism such as bile acids, amino acids, and phospholipids were 
significantly altered in this model.  
     Interestingly, we discovered that ABCB6 expression is responsive to nutrient status 
and circadian patterns. ABCB6 expression is upregulated in the fasted state and rapidly 
downregulated in response to feeding. Also, ABCB6 expression is reduced in cases of 
chronic over-nutrition such as, diet and genetic mouse models of obesity as well as in 
clinically obese humans. These findings suggest that ABCB6 acts as a nutrient sensor 
and mediates a homeostatic response through dynamic mitochondrial changes in form 
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1.1 Mitochondria: Energetic Symbionts 
     It would be difficult to overstate the importance of mitochondria regarding eukaryotic 
physiology.  Thought to have been first discovered in the 1840’s, mitochondria were 
later described to be ubiquitous in all eukaryotic life and to be “elemental organisms” 
living inside cells carrying out vital functions by Richard Altmann and others (Ernster et 
al., 1981). Following a series of discoveries that mitochondria could produce energy and 
had an independent genome (circular DNA), Lynn Margulis published her theory of 
endosymbiosis in 1967 which stated that mitochondria as we know them, probably 
came to be when an independent prokaryotic life form was endocytosed by a distant 
relative of current eukaryotes. The prokaryotic entity was permanently hosted by the 
eukaryote and the ensuing symbiotic relationship is thought to have  made possible the 
existence of multi-celled organisms because of the increased ability to provide the 
bioenergetics necessary for differentiation, growth and development (Gray, 2017). 
Although energy production is the best-known attribute of mitochondria, there are a 
plurality of known alternate functions of these organelles and current investigation 
uncovers novel roles for mitochondria at a rapid pace. They are integral to nearly every 
physiological process and pathology. Hence, the fervent research of mitochondria and 









 Figure 1.1 Basic mitochondrial structure 
                            
Physical Properties of Mitochondria       
    Figure 1.1 is an image from an electron microscope that relates the basic structure of 
mitochondria. Individual mitochondria measure from 0.5 to 10 microns and are 
enveloped by a double membrane. The outer mitochondrial membrane is relatively 
porous allowing for diffusion of small molecules. Protein channels called porins also 
allow for proteins less than 5000 Daltons to pass through the outer membrane. Proteins 
larger than this must be transported via active transport processes.  
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      The area between the two membranes is called the intermembrane space. Within 
the intermembrane space, there are discrete contact points between the two 
membranes thought to be important in several aspects such as metabolite exchange, 
protein transport, and dynamic morphological changes (Reichert et al., 2002) .  
     The inner mitochondrial membrane has many folds (cristae) that greatly increase 
surface area. The provided increased area is necessary for an abundance of proteins 
that perform key mitochondrial functions. Along with a high protein to lipid ratio, the 
inner membrane has a unique lipid composition with low triglyceride levels, a higher 
degree of fatty acid unsaturation, and cardiolipin, a phospholipid specific to 
mitochondria.  The interdependent functions of  lipid composition and IMM proteins are 
thought be crucial to mitochondrial function (Gohil et al., 2009).  
     The area interior to the inner membrane and its folds is known as the mitochondrial 
matrix which contains the enzymes that contribute to the mitochondrion’s bioenergetic 
production as well as nucleoids which contain double-stranded, circular mitochondrial 
DNA and mitochondrial protein translational machinery.  
     Although mitochondria were possibly once independent organisms, the evolution of 
increased interdependence between this organelle and the host cell is clear. 
Mitochondrial DNA and protein translational components provide just 1% of the known 
mitochondrial proteins with nuclear DNA and cytosolic transcription and translation 






Mitochondrial Energy Production 
   Just as mitochondria rely upon the cell for their protein synthesis, cells rely upon 
mitochondria for energy production. Indeed, 90-95 % of adenosine triphosphate (ATP), 
the main source of cellular biochemical energy, is produced by mitochondria with the 
balance coming from glycolysis (Skulachev, 1999).  These “powerhouses of the cell” 
can utilize different substrates (Figure 1.2) such as carbohydrates, lipids, and proteins 













                    
 
Figure 1.2 Mitochondria utilize multiple macromolecules to produce ATP.  




     Because there are relatively long periods between food intake for most mammals, 
the ability to utilize stored fat or protein reserves is a crucial physiological aspect. The 
coordination of the trafficking and utilization of nutrients between highly metabolic 
tissues and storage depots is highly dependent upon this “metabolic flexibility” provided 
by mitochondria. 
     The tricarboxylic acid (TCA) or “Krebs Cycle” and oxidative phosphorylation are the 
main components of non-glycolytic energy production. Oxidation of carbon sources by 
the TCA cycle occurs in the mitochondrial matrix and a myriad of transport, anaplerotic, 
and cataplerotic processes allow for metabolic flexibility, or the ability of an organism to 
use multiple substrates for energy production. Oxidation of these substrates by the TCA 
cycle results in the reduction of nicotinamide adenine dinucleotide (NAD) and flavin 
adenine dinucleotide (FAD) which act as “electron carriers” in the form of NADH and 
FADH2. Acceptance of electrons from these carriers allows complexes in the electron 
transport chain to “pump” protons into the intermembrane space which results in the 
creation of an electrochemical gradient and membrane potential. This “proton motive” 
force is returned to the mitochondrial matrix through ATP synthase, a protein complex 
embedded in the inner membrane. The flow of protons produces mechanical energy 
through ATP synthase which allows the formation of ATP by combining ADP with 
inorganic phosphate. The ATP produced by this “oxidative phosphorylation” can then be 
shuttled out of the mitochondria for use in the rest of the cell in exchange for ADP via 
the ADP/ATP translocase protein. Acetyl CoA, a two-carbon molecule, is the common 
metabolite in carbohydrate, fatty acid, and amino acid metabolism. It is used in the TCA 
cycle to generate carbon dioxide, ATP or GTP, NADH, and FADH2. During carbohydrate 
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oxidation, acetyl CoA can be derived from glycolysis in the cytosol. Glucose molecules 
are catabolized into two molecules of pyruvate which are then transported into the 
mitochondria and oxidized by pyruvate dehydrogenase to form acetyl-CoA. Acetyl-CoA 
is combined with oxaloacetate to form citrate. This six-carbon molecule undergoes 
various TCA cycle chemical reactions that result in the production of carbon dioxide, 
NADH, FADH2, and ATP/GTP.  Mitochondrial oxidation of fatty acids provides both 
acetyl CoA as an input to the TCA cycle and NADH used in the electron transport chain. 
Amino acids, derived from the catalysis of endogenous proteins or from the diet, after 
deamination, can also act as substrates for use in the TCA cycle.  
     There are many human pathologies related to defects in mitochondrial energy 
production including: Leigh Syndrome, mitochondrial encephalopathy lactic acidosis and 
stroke-like episodes (MELAS), deafness–dystonia syndrome (DDP), and Friedreich 
ataxia (Shoffner, 2001; Smeitink et al., 2001).  
      Mitochondrial energetic functions are also required to maintain health. Metabolic 
flexibility represents the ability to utilize various energy substrates to match energetic 
demand which results in achieving energy balance. In the modern world, this 
adaptability has become particularly important. Due to easy access to calorie-rich foods 
and a concurrent decrease in typical daily physical exertion, metabolic diseases have 
become a pandemic. The disruption of energy balance (over-nutrition plus reduced 
energy expenditure) results in mitochondrial dysfunction which is central to the 
development of Metabolic Syndrome, a collection of conditions including increased 
visceral adiposity, hyperglycemia, high cholesterol, hypertriglyceridemia, hypertension, 
and insulin resistance (Mitchell et al., 2012). Mitochondrial dysfunction is often 
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etiological in these pathologies. For example, disruption of mitochondrial ability to utilize 
fats as an energy source (incomplete fatty acid oxidation) results in the buildup of 
lipotoxic metabolites which are known to interfere with insulin signaling and increased 
inflammation (Sunny et al., 2015). Disruption of insulin signaling is often an initial step in 
the progression toward non-alcoholic fatty liver disease (NAFLD) and increased fat 
storage.  
     Obesity and the ensuing metabolic disease pathologies are currently the greatest 
health concerns in most developed countries and represent a staggering financial 
burden. Targeting mitochondrial dysfunction that has resulted from over-nutrition is an 
obvious approach to abrogate metabolic syndrome-related disease. However, there are 
several roadblocks to this approach. Mitochondria function and regulation varies greatly 
in a tissue-specific manner and our knowledge of these differences is incomplete. Also, 
congenital mitochondrial mutations are not often homogeneous due to selective 
segregation during development and because of mitochondrial replication processes. 
Partial loss of function due to heteroplasmy confounds efforts to assign dysfunction to 
specific genetic alterations. Because of these factors, mitochondrial diseases are 
currently addressed through palliative efforts and cannot currently be cured (Nunnari et 
al., 2012).  
    
1.2 Alternative Functions of Mitochondria 
     Other than energy production, mitochondria also perform a multitude of crucial 
“alternative functions”. For example, in some tissues, proton motive force can be 
“uncoupled” from ATP synthesis by increasing the permeability of the inner 
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mitochondrial membrane through the action of uncoupling proteins. Protons can then 
bypass ATP synthase to enter the mitochondrial matrix which instead of providing 
chemical energy in the form of ATP, results in heat production. This process of 
thermogenesis allows maintenance of body temperature. Recent research indicates 
there may be potential therapeutic value in the pharmacological regulation of 
thermogenesis. Interventions that increase thermogenesis may allow for the treatment 
of obesity while treatment to pharmacologically reduce thermogenesis may treat fever 
or ischemic insult from stroke (Tupone et al., 2014). 
      There are also numerous critical biosynthetic pathways that rely upon mitochondria. 
For instance, the majority of iron in the body is stored in heme-containing proteins 
(Ajioka et al., 2006) and heme biosynthesis is a coordinated process between 
mitochondrial and cytosolic enzymes and transporters (Xu et al., 2013). Additionally, the 
first and rate-limiting step in steroidogenesis is performed by the cholesterol side-chain 
cleavage enzyme (p450scc) which resides in the inner mitochondrial membrane (Miller, 
2017). Another crucial function reliant upon mitochondria is amino acid metabolism.  
The TCA cycle produces oxaloacetate and 2-oxoglutarate which contribute to the 
production of the amino acids, aspartate/asparagine, glutamine/glutamate, arginine, and 
proline (Johnson et al., 2014). Essential branched-chain amino acids such as leucine, 
isoleucine, and valine, are crucial for maintenance of muscle mass, neurotransmitter 
synthesis, maternal health and embryonic growth (Zhang et al., 2017). The catabolic 




     Citrate, a metabolite of the TCA cycle, can be exported from mitochondria as a 
building block for the synthesis of fatty acids, a component of cellular membrane 
phospholipids.  Indeed, phospholipid synthesis is a coordinated effort of both cytosolic 
and mitochondrial pathways as evidenced by the existence of mitochondrial and 
extramitochondrial redundant pathways for the production of phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), and phosphatidylserine (PS) (Scharwey et al., 2013). 
Because these glycerophospholipids are required for membrane formation, functional 
mitochondria are a fundamental requirement for cell growth and proliferation. 
Mitochondria also produce cardiolipin, a mitochondrial-specific phospholipid that is 
required for mitochondrial function.  
      Transient changes in cellular calcium levels trigger signals that result in a wide array 
of events from cell death to proliferation (Contreras et al., 2010). During cytosolic 
calcium overload, mitochondria provide a protective uptake through the mitochondrial 
calcium uniporter. Mitochondrial calcium efflux can also be utilized  to maintain 
homeostasis when cytosolic calcium concentrations normalize through mitochondrial 
Na+/Ca2+ antiporters (Contreras, et al., 2010). 
     The urea cycle represents another protective function of mitochondria. Amino acid 
catabolism produces the toxic waste product ammonia which must be converted to urea 
for excretion. The first two steps of the five-step process take place in mitochondria. 






1.3 Mitochondrial Dynamics and Cell Signaling 
     Mitochondria are crucial mediators of cellular signaling. They act as a 
communication and signaling hub because their structure and function are 
physiologically responsive to intracellular signals and by extension, extracellular signals. 
The molecular mechanisms for the transmission of extracellular signals to mitochondria 
are a current area of investigation. Signaling molecules are also sent from the 
mitochondria to the nucleus (retrograde signaling) to affect cellular responses. 
Mitochondria directly participate in signaling through interaction or trafficking of proteins, 
lipids, and ions on the outer mitochondrial membrane, by the production of metabolites, 
and through alterations in morphology and motility (Tait et al., 2012). 
     It is important to consider that mitochondria are not static entities and that 
contributions of mitochondria to cellular function and signaling are dependent upon the 
dynamic control of intrinsic mitochondrial properties such as membrane potential, TCA 
flux and ETC activity which are themselves interrelated.  In addition, mitochondria are 
motile and undergo morphological changes. Indeed, two neighboring individual 
mitochondria can either fuse (Figure 1.3) into one, or a single mitochondrion can “split” 
into two daughter mitochondria. These fusion/fission processes allow for the sharing 
and segregation of mitochondrial components as well as the fine-tuning of mitochondrial 
function. Mitochondrial also interact with other cellular organelles such as the 
endoplasmic reticulum and lysosomes to facilitate signaling and intra-cellular 
communication. Mitochondrial dynamics is a term used to comprehensively describe 
mitochondrial motility, intracellular localization and morphology. Mitochondrial dynamics 
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are inseparably linked to the major cellular signaling categories of cell death, reactive 
oxygen species (ROS), and ATP production in response to demand. 







Figure 1.3 Mitochondrial fusion and fission. Reprinted with permission from Zhan M, et al. 
Mitochondrial dynamics and emerging role in renal pathophysiology. 2013. Kidney International. 




     Mitochondria are tethered to the cytoskeleton which allows translocation in an 
energy consuming process. Intracellular localization of mitochondria is known to play 
important roles in cellular responses. For example, hypoxia has been shown to induce 
perinuclear clustering of mitochondria. This translocation allows proximity-driven ROS 
signaling that produces a nuclear transcriptional response to abate detrimental ROS-
mediated effects (Al-Mehdi et al., 2012). Spatial distribution of mitochondria in parotid 
acinar cells is thought to be integral to calcium mediated function within these highly 
polarized cells. Firstly, the intercellular distribution of mitochondria acts as a buffer to 
protect the basolateral portion of the cell from calcium waves produced due to 
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specialized cellular functions via mitochondrial calcium buffering. Secondly, 
mitochondria are positioned so that the calcium-driven ATP production is selectively 
utilized for exocytosis (Bruce et al., 2004). Perhaps the most profound example of the 
need for mitochondrial motility is found in neurons. These cells, which can be up to a 
meter in length, require most mitochondria at the synapse to support neuronal firing. 
However, mitochondrial biogenesis takes place in the soma, at a great distance from 
the synapse. Mitochondria must translocate in order to provide ATP at the proximal 
location of neurons (Course et al., 2016). Also, mitochondria are requisite for the 
production of neurotransmitters at synaptic gaps (Course, et al., 2016). Neurons 
themselves have a long lifespan and have high energetic demand. Consequently, older 
mitochondria within neurons must fuse with newer ones to maintain genome integrity 
and function as they traverse the distance of axons illustrating the necessity of both 
major facets of mitochondrial dynamics; translocation and fusion/fission. Additionally, 
there are large neurotransmitter-stimulated calcium influxes at neuronal synapses. The 
aforementioned calcium buffering function of mitochondria is protective against 
excitotoxity at these synaptic gaps further illustrating the vital role of mitochondrial 
mobility (Nunnari, et al., 2012).    
 
Mitochondrial Fusion and Fission 
     Mitochondrial morphology is controlled by a balance between the processes of 
mitochondrial fusion, or the physical joining of separate mitochondria, and fission, the 
division of a single mitochondria to multiple mitochondria. A loss of fusion activity itself 
results in fragmented mitochondria and an increase of fusion results in elongated, 
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tubular morphology whereas a gain of fission results in more fragmentation and its loss 
results in a return to the elongated form.  Mitochondrial motility and fusion/fission 
activities and the regulation thereof vary greatly depending upon cellular status or 
environment. The variability of these processes within different anatomical structures 
contributes to the pleiotropic phenotypes seen during the loss of mitochondrial dynamic 
functions (Nunnari, et al., 2012).  
     The process of mitochondrial fusion and fission are carried out by a group of 
dynamin-like GTPases. In mammals, the proteins involved in fusion are Mitofusin1 
(MFN1), Mitofusin 2 (MFN2), and Optic atrophy type 1 (OPA1). Fusion is a two-step 
process (Meeusen et al., 2004) in which outer membrane proteins MFN1 and MFN2 
accomplish the fusion of the outer membrane. Inner membrane fusion is dependent 
upon OPA1.  
  Increased mitochondrial fusion is often seen in metabolically active cells and the 
process results in an extensive electrically connected network allowing for the 
distribution of membrane potential across cellular oxygen gradients thereby spatially 
distributing energy production.  Fusion is often described as a protective response 
against cellular stressors such as energy deprivation and ROS. Mitochondrial fusion 
acts as a defense against ROS-mediated mitochondrial DNA damage by facilitating the 
“mixing” of gene products responsible for oxidative phosphorylation. In a process 
termed complementation, the combining of mitochondrial contents allows for well-
functioning components in one mitochondrion to compensate for damaged components 
of another. It is also thought that defective components are segregated during fusion to 
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prepare for eventual removal which can be mediated via fission (Westermann, 2008) 
(Youle et al., 2012).   
          The first step of mitochondrial membrane fusion is a remarkable process in which, 
protein complexes in distinct mitochondria are coordinately formed in trans allowing the 
fusion of four membranes (two outer and two inner) despite the repellant negative 
charges of individual mitochondria. Studies in yeast systems indicate that outer 
membrane fusion can be initiated by reversible ubiquitylation (Wiedemann et al., 2013). 
However, knowledge of molecular mechanisms of initiation events in mammals is 
incomplete. Numerous cellular events are known to coincide with fusion such as energy 
deficiency, calcium efflux, and cellular division. For example, in some plants and kidney 
cells, all mitochondria fuse as a single interconnected entity to allow proper distribution 
of mitochondrial DNA prior to cytokinesis. This is in stark contrast to less drastic and 
transient fusion events in response to changes in energy demand. Considering the 
plurality of cellular events associated with mitochondrial fusion, it is likely that initiation 
arises from distinct mechanisms. The mechanistic details of the process of 
mitochondrial outer membrane fusion itself are also unclear but ablation of GTP 
binding/hydrolysis in fusion proteins completely abolishes membrane fusion 
(Wiedemann, et al., 2013). There are two mechanistic models of mitochondrial fusion 
considered to be likely. First, the nucleotide binding state of mitofusins may promote 
recruitment of other proteins required to complete the process or secondly, mitofusin 
GTP hydrolysis may provide the mechanochemical energy required to allow fusion 
through membrane conformational changes or close apposition (Wiedemann, et al., 
2013). It is known that mitofusins can form both homo and heterodimers (MFN1/MFN1 
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MFN2/MFN2, MFN1/MFN2) and that coordination of trans mitofusins interaction is 
mediated by heptad repeats (HR1 and HR2) (Eura et al., 2003). Interaction of trans HR 
domains between mitofusins are thought to tether mitochondrial pairs but not at a 
distance to allow spontaneous fusion. This tethered complex forms an intermediate 
complex after which, the GTPase activity of both mitofusins bring to completion outer 
membrane fusion (Koshiba et al., 2004), (Meeusen, et al., 2004).  
     As mentioned above, inner membrane fusion is a distinct process, but it is unknown 
what causes the transition from outer to inner membrane fusion. However, it has been 
demonstrated that following trans mitofusin complex formation, the lipid bilayer contents 
from each prospective mitochondrion are mixed (Frohman, 2015). Mixing of membrane 
components may be a factor in the accomplishment of complete mitochondrial fusion.  
     The inner membrane dynamin-like GTPase OPA1 facilitates inner mitochondrial 
membrane fusion and is required for mitochondrial fusion in mammals (Song et al., 
2007).  OPA1 knockout mice die in mid-gestation and mutations in OPA1 are known to 
be causative of the heritable human ocular disease, optic atrophy type 1. OPA1 has 8 
isoforms due to alternate mRNA splicing and these various isoforms are subject to post-
translational proteolytic processing resulting in long and short forms. Unprocessed 
OPA1 contains a mitochondrial targeting sequence and cleavage may be regulated 
based upon its import into the inner membrane (Wiedemann, et al., 2013). Drosophila 
models deficient in short-form OPA1 display drastically fragmented mitochondria 
demonstrating the long form alone is insufficient for fusion (McQuibban et al., 2003). 
Also, disruptions in the ratio of long and short forms results in mitochondrial morphology 
alterations (Herlan et al., 2004) indicating the need for both isoforms to maintain normal 
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fusion. Paradoxically, both OPA1 knockout and overexpression models display 
fragmented mitochondria. OPA1 has also been shown to be involved in the 
maintenance of cristae morphology as yeast systems deficient for OPA1 have 
disorganized, poorly invaginated cristae. It has been postulated therefore, that the 
disruption of fusion in both models may be secondary to OPA1 mediated cristae 
structure (Wiedemann, et al., 2013). Mechanistic details of inner membrane fusion are 
scarce but GTP availability and mitochondrial membrane potential are crucial aspects. 
Dissipation of mitochondrial membrane potential using ionophores or limiting GTP 
concentrations allows outer membrane fusion but blocks inner membrane fusion 
demonstrating both that outer membrane and inner membrane fusion are distinct steps 
and that GTP hydrolysis and maintenance of membrane potential are necessary for 
complete mitochondrial fusion (Mattenberger et al., 2003), (Meeusen, et al., 2004).  
     Mitochondrial fission is mediated by dynamin-related protein 1 (DRP1). Disruption of 
DRP1 function results in elongated, tubular mitochondrial morphology (Youle, et al., 
2012). DRP1 is localized mainly in the cytosol but a portion of the population is situated 
on the outer mitochondrial membrane and possibly acts as a marker of future fission 
events (Chan, 2006). The process occurs in four stages which are translocation of 
cytosolic DRP1 to the outer mitochondrial membrane, assembly of DRP1 oligomers, 
GTP hydrolysis, and disassembly (Hu et al., 2017). Mitochondrial fission can be initiated 
by calcium efflux from the endoplasmic reticulum (ER) to the mitochondria or from 
CDK1 during mitosis. Also, increased ROS can initiate fission via PKC1 delta (Hu, et al., 
2017). Several accessory proteins have been shown to play a role in the recruitment of 
DRP1 from the cytosol to the mitochondrial outer membrane including mitochondrial 
18 
 
fission factor (MFF), mitochondrial fission 1 protein (FIS1), and mitochondrial elongation 
factors 1 and 2 (MiD51 and MiD49).  
     Endoplasmic reticulum mitochondrial-associated membranes seem to act as 
markers as a guide for fission sites and DRP1 recruitment (Willems et al., 2015). Exact 
mechanistic details of DRP1 recruitment are still under investigation and are 
model/species dependent. Once the recruitment stage is complete, DRP1 undergoes 
oligomerization. Conserved regions of individual DRP1 units fold back on each other to 
form a stalk. This complex induces a spiral effect that brings GTPase regions of DRP1 
units into a position that favors hydrolysis and the mechanochemical force required for 
constriction is produced enabling the scission of outer and inner membranes (van der 
Bliek et al., 2013).  
     Mitochondrial fission machinery is regulated by multiple post-translational 
modifications including SUMOlation, s-nitrosylation, ubiquitination, O-GlcNAcylation, 
and phosphorylation of DRP1. There are several phosphorylation sites that positively 
and negatively regulate DRP1 activity (Hu, et al., 2017). Accessory proteins such as 
MFF are also regulated via phosphorylation.  
     Because mitochondria cannot be formed de novo, mitochondrial fission is required 
for cell division. Fission allows for the increased population of mitochondria that newly 
formed cells require. Like fusion, fission is often the consequence of cellular stress but 
rather, occurs in late stages when the protective response of fusion has reached 
capacity. Fission allows for the clearance of defective mitochondria and recycling of 




Mitochondrial Dynamics and Cell Death      
     Mitochondria carry out well-characterized functions involved in regulating programed 
cell death in response to both extracellular (extrinsic) and intracellular (intrinsic) stimuli. 
Apoptosis is a critical factor for the formation of anatomical structures during 
development and for maintenance of cellular populations in tissues and organs 
throughout adulthood and during the aging process (Elmore, 2007). During programmed 
cell death, cellular components are degraded in a controlled manner with no adverse 
effects to surrounding cells. The extrinsic apoptotic pathway (receptor-mediated) is 
initiated via “death receptors” such as first apoptosis signal (FAS) and tumor necrosis 
factor (TNF) receptors that are activated by immune responses or trauma from without 
the cell. The intrinsic pathway also called “mitochondrial-mediated apoptosis”, is 
initiated via mitochondrial outer membrane permeabilization (MOMP) and release of 
pro-apoptotic factors such as cytochrome c, apoptosis inducing factor (AIF), and 
endonuclease G from the mitochondria. There is extensive crosstalk between extrinsic 
and intrinsic pathways with mitochondria playing crucial roles in both. Mitochondrial 
morphology is tightly linked to apoptosis (Figure 1.4). In general, fission is pro-apoptotic. 
During the early stage of apoptosis, cytosolic DRP1 is recruited to the OMM resulting in 
fragmentation and cytochrome C release. RNAi induced knockdown of DRP1 prevents 
cytochrome c release mitigating apoptosis (Youle, et al., 2012). Bcl-2-associated X 
protein (BAX), a well characterized mediator of apoptosis resides in the cytosol in non-
apoptotic cells and like DRP1, is recruited to the OMM co-localizing with DRP1 and 
MFN2 which induces cytochrome c release. Again, knockdown of DRP1 prevents 
cytochrome c release despite BAX translocation (Youle, et al., 2012). However, fission 
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is not universally pro-apoptotic but rather is dependent upon the source of stimuli. In the 
case of an apoptotic calcium wave through a mitochondrial network, fragmentation can 
block the transmission of the calcium signal thereby blocking apoptosis (Perfettini et al., 
2005).  Mitochondrial fusion is generally anti-apoptotic. Bcl-2 homologous 
antagonist/killer (BAK) and BAX have been shown to promote fusion in healthy cells via 
maintenance of MFN2 distribution on the OMM (Youle, et al., 2012). Knockdown of 
MFN1 and MFN2 promotes fragmentation and sensitivity to apoptotic stimuli while 
overexpression delayed BAX translocation and cytochrome c release (Suen et al., 
2008). Further, the bulk of cytochrome c resides in cristae junctions and its release is 
dependent upon OPA1 cristae remodeling activity. Like the mitofusins, efficient 
knockdown of OPA1 can induce apoptosis (Suen, et al., 2008) illustrating the anti-









           
 Figure 1.4 Mitochondrial dynamics and cell death are inter-related processes. Reprinted 
with permission from Zhan M, et al. Mitochondrial dynamics and emerging role in renal pathophysiology. 
2013. Kidney International. 83(4):586-581. https://doi.org/10.1038/ki.2012.441 (Zhan, et al., 2013) 
 





Mitochondrial Dynamics and Reactive Oxygen Species 
     As a consequence of respiration, mitochondria are the main cellular source of 
reactive oxygen species (ROS). The main sites of mitochondrial ROS production are 
Complexes I & III in the electron transport chain (ETC). During the process of electron 
transfer, some electrons “leak” rather than being transferred from complex I and 
complex II to complex III resulting in a single electron reduction of molecular oxygen 
thus forming the superoxide anion. Superoxide cannot readily pass through membranes 
and is quickly converted to hydrogen peroxide by mitochondrial dismutase. Hydrogen 
peroxide is freely diffusible and is converted to water by peroxidases and peroxidoxins 
within mitochondria and by catalase in the cytosol and peroxisomes. In the presence of 
metals, superoxide and hydrogen peroxide can be converted to the highly reactive 
hydroxyl radical. Free radical species such as these can cause cellular damage 
including membrane disruption by lipid peroxidation, DNA damage via hydrogen 
abstraction, and oxidation-mediated disruption of protein function.  
     Eukaryotes have developed endogenous anti-oxidant defenses such as the “non-
critical” nucleophile glutathione. In addition to the enzymatic conversion (via 
peroxidases) of free radicals to water, glutathione acts as an antioxidant by donating its 
electrons to free radicals. The oxidized form (GSSG) is then recycled to the reduced 
form (GSH) by glutathione reductase. Despite the potential damage caused by these 
reactive species, healthy cells maintain a constant low level of ROS. Indeed, some 
reactive oxygen species are valuable signaling molecules that are necessary for proper 
development and cellular function (Di Meo et al., 2016). A physiological level of ROS 
promotes cellular production of antioxidant molecules necessary for defense against 
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environmental sources of ROS such as ionizing radiation and xenobiotics (Yamashita et 
al., 1997). Further, ROS levels dictate cellular proliferation/death balance and innate 
immune responses (Zuo et al., 2015).  
     There is sufficient evidence to demonstrate that mitochondrial form and function 
mediate ROS dependent cellular responses. Indeed, ROS levels regulate mitochondrial 
fusion and fission and reciprocally, mitochondrial morphology can modulate ROS levels. 
Mitochondria within cells exposed to exogenous hydrogen peroxide have increased 
fragmentation while subsequent exogenous antioxidant treatment results in increased 
fusion (Willems, et al., 2015) demonstrating that fission fusion balance is affected by 
ROS levels. The interrelation of mitochondrial dynamics, function, and ROS is illustrated 
by studies that show greatly reduced complex I activity results in mitochondrial 
fragmentation and increased ROS (Willems, et al., 2015). Other studies demonstrate 
DRP1-dependent fragmentation due to increased nitric oxide levels which is attenuated 
by nitric oxide scavengers (Willems, et al., 2015). In yeast, peroxidation of the 
mitochondrial-specific phospholipid cardiolipin, results in the functional disruption of the 
fusion protein OPA1. In this case and in the cases of hydrogen peroxide exposure and 
reduced complex I activity, loss of membrane potential is a common theme. 
Mitochondria with low membrane potential are often targeted for degradation through 
mitophagy. Decreased membrane potential increases E3 ubiquitin ligase Parkin activity 
which in turn regulates the degradation of DRP1 and MFN2 illustrating the connection 
between ROS levels, mitochondrial function, and mitophagy. Fragmentation facilitates 
the removal of defective mitochondria through mitophagy.  Conversely, mitochondria 
that have undergone fusion may avoid degradation because their increased size 
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prevents entry into the autophagosome (Nunnari, et al., 2012). ROS-induced s-
nitrosylation influences Parkin, a E3 ubiquitin ligase that regulates DRP1 and MFN2 
degradation which ultimately controls mitochondrial morphology. Additionally, several 
fusion/fission proteins undergo ROS-mediated posttranslational modifications (PTMs) 
that regulate their function illustrating an interdependent relationship between cellular 
redox status, mitochondrial dynamics and mitochondrial quality control.   
 
Mitochondrial Dynamics and Energy Balance 
     Mitochondria are highly responsive to cellular energetic demands. Reciprocally, 
mitochondrial ATP production dictates overall cellular function. Bioenergetic balance is 
coordinated by regulation of cellular activity and energy production in response to 
nutrient availability (Benard et al., 2010). Nutrient availability is sensed by mammalian 
target of rapamycin kinases that broadly influence metabolic state 
(anabolism/catabolism). Energy status is determined by the adenosine monophosphate 
(AMP) to adenosine triphosphate ratio (ATP) and NAD+/NADH levels which are sensed 
by amp-activated protein kinase (AMPK) and sirtuins respectively. These energy 
sensors regulate energy production via mitochondrial biogenesis regulation, influencing 
catabolic/anabolic state, and through the regulation of energy substrate usage 
(metabolic flexibility).  
     Metabolic control analysis (MCA) is the study of cellular energy flux. It involves 
investigating the expression and activity of enzymes involved in transport and oxidation 
of energy substrates and the subsequent production of ATP. Performance of MCA is 
highly complex due to the diversity of the energetic needs of various organs and 
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tissues. For example, the regulation of mitochondrial bioenergetics in cardiac and 
skeletal muscle are dictated mainly by ETC activity while in the brain, liver and kidney, 
the main determinant is ATP production (Benard, et al., 2010). Indeed, not only are 
there vast differences in total mitochondrial content and protein expression levels 
between tissues but proteomics reveals that subsets of mitochondrial proteins are 
unique to various organ systems illustrating the complexity of mitochondrial biology. 
     In addition to the regulation of metabolic control via the cytosolic nutrient and energy 
sensors, mitochondrial fusion and fission rapidly fine tunes energy balance in response 
to energetic status and demand. Increasing evidence suggests that there is an 
interdependent relationship between cellular energetic status and mitochondrial 
dynamics that maintains overall energy homeostasis.  
     Mechanisms that link nutritional state, mitochondrial dynamics, and mitochondrial 
energy production are active areas of investigation but clearly, mitochondrial 
morphology is influenced by nutritional state. Diet induced obesity rat models result in 
decreased mitochondrial fusion in skeletal muscle parallel to decreased MFN2 (Bach et 
al., 2005). Additionally, genetic and diet induced obesity models result in increased 
fission protein expression and increased fragmentation (Putti et al., 2015). However, 
fusion and fission responses to increased energy substrates are dependent upon the 
type of energy substrate concerned. Mice fed lard-based diet exhibit increased 
mitochondrial fragmentation in parallel with decreased MFN2 expression. Conversely, 
diets supplemented with polyunsaturated fats had increases in mitochondrial fusion 
which was negated with siRNA knockdown of MFN2 indicating that fusion/fission 
machinery is responsive and highly selective to nutritional inputs (Zhang et al., 2011). 
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Nutrient deprivation also results in selective mitochondrial morphology responses. In 
one cell-based model, glucose or serum starvation results in increased fragmentation 
while nitrogen-based nutrient deprivation results in increased fusion. Mixed nutrient 
deprivation results in increased fusion. Caloric restriction however, results in increases 
in DRP1 and FIS1 with no change in fusion proteins (Khraiwesh et al., 2013). One could 
infer from these data that dynamic responses are dependent upon the type of nutrient 
deficiency and the length of starvation period (Putti, et al., 2015).  
     In the above listed studies, the general finding is that mitochondrial fragmentation is 
accompanied by reduced mitochondrial function and increased ROS production 
whereas increased fusion results in increased oxidative phosphorylation efficiency. It is 
postulated that mitochondrial fragmentation could occur as a protective mechanism in 
the context of high nutrient status by increasing total surface area to facilitate oxidation 
of the surplus substrate supply. An exception is seen in the case of prolonged caloric 
restriction. Increased fragmentation in this case was thought to support mitochondrial 
biogenesis to increase ATP production in this context. This view is supported by an 
increased mitochondrial number per cell with decreased ROS production and no 
decrease in ATP production. This agrees with studies that show caloric restriction 
increases longevity because of reduced ROS production. There are limited studies 
supporting the idea that increased mitochondrial fusion directly causes increased 
mitochondrial function and efficiency (Mitra et al., 2009), (Tondera et al., 2009) and 
mechanistic details are scarce in this regard. However, some studies suggest that 
mitochondrial remodeling proteins enable the formation of “super complexes” of 
individual ETC members that are in complex to afford a synergistic efficiency (Genova 
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et al., 2014). Other studies demonstrate that fusion allows a complementation of 
mitochondrial DNA, a situation in which two separate mitochondria, each with a different 
set of genetic mutations compensate for gene defects by the “sharing” of their 
respective genomes. This principle was illustrated when two cell lines, one with a 
normal genome, and one with mitochondrial DNA mutations that caused respiratory 
defects were hybridized. After a few days, respiratory capacity was restored  in the loss 
of function mutation group, ostensibly due to the transmission of functional genes from 
the healthy group to the other (Ono et al., 2001). Mouse fibroblasts deficient for MFN1 
and MFN2 can maintain mitochondrial DNA content but rapidly lose membrane 
potential. However, cells with fragmented mitochondria that still possess some fusion 
activity maintain their respiratory capacity (Westermann, 2012) indicating that 
mitochondrial DNA complementation rather than morphology supports the increase in 
function.  
     Mitochondrial fission positively influences mitochondrial function through selective 
degradation of dysfunctional mitochondria. After a fission event, daughter mitochondria 
with low membrane potential have lower fusion protein expression making it unlikely 
that they will undergo fusion in the future and will be targeted for mitophagy thereby 
maintaining a healthy mitochondrial population. This contrasts with pathogenic 
fragmentation seen in response to chronic overfeeding or genetic disruptions in which 
diminished ATP production and increased ROS is seen (Jheng et al., 2012).  
     The above examples illustrate the interdependent relationships that exist between 
mitochondrial dynamics, nutritional state, energy demand, and energy production. 
However, there is a considerable gap of knowledge with respect to control mechanisms. 
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Individual mitochondria acquire genome diversity (heteroplasmy) in different cell 
populations and indeed, even within the same cell, evidence suggests there are 
subpopulations of mitochondria making these groups functionally unique (Benador et 
al., 2018). Also, due to the disparate, yet connected functionality of different organs in 
the maintenance of whole-body energy balance, the regulation of mitochondrial 
dynamics is necessarily context dependent. Methods previously and currently used to 
study mitochondrial function include the utilization of immortal or primary cells and 
mitochondrial isolation ex vivo. These methodologies are artefactual and extremely 
limited in giving a clear picture of how mitochondrial dynamics influences energy 
homeostasis under normal physiology in vivo and much less, under pathogenic 
conditions. New technologies such as nuclear magnetic resonance (NMR) analysis of 
mitochondrial transport chain activity in situ, will advance the field of study of this crucial 
aspect of cellular biology.    
 
1.4  Mitochondrial Transporters 
     Just as mitochondria themselves are not static entities, dynamic control of the 
transport of substrates, waste products, lipids, and proteins to and from mitochondria 
are a requisite for life. As mentioned previously, mitochondria are enveloped in a double 
membrane. The outer membrane is comprised mainly of lipids and permeable to 
molecules of 10 kilodaltons or less but the inner membrane is highly organized, 
proteinaceous and impermeable to diffusion except for very small molecules such as 
oxygen and water. ATP produced within mitochondria is needed throughout the cell and 
is derived from ADP. Thus, ATP/ADP exchange is a crucial transport function within the 
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cell. Further, most enzymes required for mitochondrial function are synthesized in the 
cytosol. Therefore, the most obvious needs for mitochondrial transport are an exchange 
of ADP/ATP, bidirectional trafficking of TCA cycle substrates, and import of nuclear 
encoded mitochondrial proteins, all of which require active transport processes.  
      ATP-Binding Cassette Transporters (ABC transporters) belong to one of the largest 
super families of proteins and are highly conserved throughout evolution (Davidson et 
al., 2008). As active transporters, they couple the binding and hydrolysis of ATP to the 
active transport of  various substrates across lipid membranes or from one double-
membrane leaflet to another (Quazi et al., 2012). ABC transporters consist of two 
hydrophilic nucleotide binding domains (NBDs) and at least two hydrophobic 
transmembrane domains (TMDs). The nucleotide binding region is highly conserved and 
serves as a common transport mechanism among the superfamily of proteins (Locher, 
2009). The NBD consists of Walker A and B sequence motifs that allow the binding and 
hydrolysis of ATP and a signature, “C” region located upstream of the Walker B site that 
contains the consensus sequence (LSGGQ) which distinguishes ABC transporters from 
other ATP binding proteins (Kay et al., 2012). The NBDs are located on the cytosolic 
face and typically pump compounds out of the cell or into organelles such as the 
endoplasmic reticulum, mitochondria, peroxisomes, and lysosomes (Procko et al., 2009). 
The transmembrane domains typically consist of six membrane spanning segments and 
serve as substrate binding sites and are less conserved  allowing for transport of a 
diverse array of substrates within the ABC family members (Kaminski et al., 2006). 
Eukaryotic ABC transporters are divided into seven subfamilies (A through G) according 
to sequence similarity and phylogenic analysis (Vasiliou et al., 2009). ABC transporters 
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are further divided into full or half transporter categories. Full transporters contain two 
NBDs and two TMDs within a single polypeptide chain and are a complete, fully 
functional unit. Half-transporters contain only one NBD and one TMD and must homo or 
heterodimerize to form a fully functional transporter. Figure 1.5 is a graphic depiction of 
the basic organization and structure of ABC transporters. 
     
 
Figure 1.5 Basic structure of an ABC transporter. (TMD)-transmembrane domain. (NBD)- 
Nucleotide binding domain. 
 
 There are four known mitochondrial ABC transporters all belonging to the “B” 
subfamily. ABCB7, ABCB8, and ABCB10 are localized to the inner membrane and have 
proposed functions including iron-sulfur cluster and heme biosynthesis.  ABCB6 is the 
only ABC transporter known to be localized to the outer mitochondrial membrane. Due 
to the highly hydrophobic nature of ABC transporter TMDs, they would be predicted to 
be directed co-translationally to the ER membrane. However, it has been demonstrated 
that a long, positively charged N-terminal leader sequence re-routes the mitochondrial 
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ABC transporters to the mitochondria (Zhang, et al., 2011). The exception to this 
proposed mechanism is ABCB6 which has no defined mitochondrial targeting sequence 
and has been found in the secretory locations of the ER, Golgi, and plasma membrane 
(Tsuchida et al., 2008). How ABCB6 is targeted to mitochondria is an active area of 
investigation. 
     ABCB6 is a member of the “B” subfamily which is further divided by homology into 
the multidrug resistance (MDR) and the transporter associated with antigen processing 
(TAP) classes. The ABC B subfamily is unique in that the entire set of transporters 
within the class are present in all mammals (Locher, 2009). Another distinguishing 
characteristic of this subfamily is that it includes both full and half transporters. The 
conservation of ABC B subfamily members in humans and mice demonstrate that 
murine model is useful for understanding ABCB6 functionality in humans. ABCB6 was 
initially cloned while screening for novel drug resistance-related genes in the liver using 
a partial ABCB1 or P-glycoprotein sequence as a probe. Subsequently, the full-length 
protein was independently cloned and named UMAT (ubiquitously expressed 
mammalian ABC half-transporter) or MTABC3 (mammalian mitochondrial ABC protein 3 
(Hirsch-Ernst et al., 1998; Mitsuhashi et al., 2000). These terms are synonymous with 
ABCB6 as it is referred to in the currently accepted nomenclature. ABCB6 is a 
transmembrane protein with the full transporter having two TMDs and two NBDs. The 
NBD shows similar homology to other ABC transporters and faces the cytosol 
(Kurashima-Ito et al., 2006).  ABCB6 is nearly universally expressed with high protein 
expression seen in liver, gallbladder, stomach, duodenum, kidney, bladder, testis, 
epididymis, thyroid, and bronchus (Uhlen et al., 2015). 
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     Non-functional or null mutations in Abcb6 have been shown to be involved in several 
human diseases and pathologies. ABCB6 is known to be localized in the plasma 
membrane (PM) of red blood cells and thought to be involved in the export of 
porphyrins. Studies have identified ABCB6 as the genetic basis of the Langereis blood 
type. Patients with Abcb6 null alleles are at for risk hemorrhagic complications during 
transfusions (Helias et al., 2012). In another blood-related pathology, Abcb6 mutations 
are responsible for Familial Pseudo Hyperkalemia, a condition that results in increased 
potassium in whole blood or serum (Andolfo et al., 2013). Dyschromatosis universalis 
hereditaria presents as areas of hyper or hypo skin pigmentation. Ocular coloboma is 
an inherited developmental disease that results in incomplete closure of the optic 
fissure. Loss of function of ABCB6 is causative for both conditions (Wang et al., 2012), 
(Zhang et al., 2013). Studies in mice indicate that ABCB6 plays a role in the 
development in atherosclerosis (Murphy et al., 2014). The variation in the severity of 
these disease phenotypes associated with ABCB6 suggest incomplete penetrance. 
Moreover, the pleiotropic nature of these conditions supports multiple and/or tissue-
dependent physiological roles.  
     ABCB6 is highly conserved and unique in its mitochondrial outer membrane 
localization. Because of this, considerable efforts have been taken to ascertain its 
physiological function. Initially, because of its sequence similarity (46%) to the yeast 
mitochondrial iron transporter ATM1p, it was thought that ABCB6 may be an ATM1p 
ortholog and would play a role in iron homeostasis. However, it was discovered that 
ABCB7 was actually the functional ortholog of ATM 1p (Pondarre et al., 2007). Abc6 is 
highly expressed in the gut of Caenorhabditis elegans and is required for iron uptake 
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from diet again suggesting a role in iron/heme-related processes (Krishnamurthy et al., 
2011). Additional in vitro and ex vivo studies demonstrated that ABCB6 binds heme-
related molecules (porphyrins) suggesting a role in heme biosynthesis (Krishnamurthy 
et al., 2006). However, cohort studies using Lan -  samples identified no impairment of 
erythropoiesis (a heme-dependent process) and only slight increase in porphyrin in 
subject red blood cells with no incidents of anemia (Helias, et al., 2012). This study 
refutes the presumed role of the plasma membrane form of ABCB6 in porphyrin export 
and suggests another plasma membrane transporter may compensate for the loss of 
ABCB6. Whole-body and liver specific  Abcb6 mouse knockout models show no 
significant decrease in heme or upregulation of other heme biosynthesis pathway genes 
(Chavan et al., 2015) suggesting the absence of need for outer membrane heme active 
transport or an additional, yet unidentified transport process.  
     A significant challenge in determining the physiological roles of ABC transporters is 
their promiscuity. Although they are perhaps best known for promotion of drug 
resistance in humans through cellular efflux of hydrophilic pharmaceuticals, the 
discovery that ABCB4 was responsible for the secretion of PC into bile (Borst et al., 
2000), lead to the idea that ABC transporters can and do transport hydrophobic 
substrates including lipids. This concept has been confirmed in several instances. 
Streptococcus produce the toxin doxorubicin, a hydrophobic entity that can enter cells 
through simple diffusion. Intuitively, bacteria that produce these toxins would require 
efflux transporters to protect themselves from the poisons they produce. Indeed, that is 
the case as the streptococcus that produces doxorubicin also encodes an ABC 
transporter that transports it out of the cell (Borst, et al., 2000). Nearly half of the 48 
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human ABC transporters transport lipids or lipid-related compounds like cholesterol and 
bile acids in addition to hydrophilic substrates (Schou et al., 2012). Examples include 
ABCD4 which transports long-chain fatty acids into peroxisomes, and ABCB4 which 
transports phosphatidylcholine via floppase activity. (Neumann et al., 2017).  
     Interestingly, ABC transporter conformation and activity are affected by their cellular 
environment which they help to maintain (Neumann, et al., 2017).  It has been 
demonstrated that this interrelationship has physiological consequences regarding 
energy metabolism. ABCB11, a bile acid transporter influences glucose and lipid 
homeostasis through the signaling actions of bile acids (Ma et al., 2014). Genetic 
alterations in ABCA1 result in high-density lipoprotein (HDL) deficiency (Tangier 
disease) which disrupts reverse cholesterol transport. Abcg1 is expressed in 
macrophages, adipose tissue, and pancreatic beta cells and is responsible for the 
regulation of insulin secretion, cholesterol homeostasis, and adiposity in a context-
dependent manner (Schou, et al., 2012), (Frisdal et al., 2015).  
     Our current studies focus on the role of the ABC transporter ABCB6 in the 
maintenance of energy homeostasis. We discovered that genetic manipulation of Abcb6 
expression in mice resulted in observable phenotypes including, lower than predicted 
Mendelian KO progeny and altered growth pattern. Liver microarray data from these 
studies supported these phenotypes as they showed disturbances in organismal 
survival, lipid metabolism, metabolic disease, and carbohydrate metabolism (Table 1) 
(Chavan, et al., 2015). These initial observations prompted the current study which 











































































2.1 Study Objective 
     The world’s current population is the most obese in history according to the 
National Health and Nutrition Examination Survey. Except for a relatively small 
percentage of congenital etiologies, the increase in obesity is due to lifestyle 
choices. Nonetheless, interventions of diet and exercise mostly fail due to lack of 
sustained compliance which necessitates alternative treatment options. Obesity in 
and of itself is not necessarily pathological. However, there is voluminous clinical 
evidence that incidents of various pathologies are closely associated with increased 
body fat including diabetes mellitus, insulin resistance, and the metabolic 
syndrome.(Bray, 2004).  
     Progression toward obesity begins with positive energy balance. Imbalances in 
the type of dietary calories are also implicated in increased adiposity. Mitochondria 
are the first defense against obesity as they are key to metabolic flexibility. Chronic 
positive energy balance dysregulates mitochondrial adaptive responses and 
eventually causes mitochondrial dysfunction. Parallel to this process, capacity to 
store a surfeit of energy is overwhelmed leading to dyslipidemia and increased 
postprandial blood glucose. This leads to systemic stress and further mitochondrial 
dysfunction in a feed-forward manner. Non-alcoholic fatty liver, type II diabetes, 
hypercholesterolemia, and hypertension are manifestations of this maladaptive 
process and could ultimately be described as a failure of metabolic flexibility.  
     It is known that dynamic regulation of mitochondrial form and function in 
response to changes in nutritional status is required for metabolic flexibility but there 
are no pharmacological therapies that target this axis. Additionally, current 
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understanding of how mitochondrial transport systems affect mitochondrial dynamics 
is extremely limited. In this study, we show that the alteration of expression of a 
single mitochondrial transporter, ABCB6 disrupts mitochondrial dynamics leading to 
metabolic syndrome. 
     Previous studies demonstrated that loss of ABCB6 resulted in alterations of 
hepatic function and metabolism. Overall observable phenotypes were pleiotropic 
but among them was a disturbance in growth and body weight. Further, it was 
discovered that ABCB6 expression was regulated by nutrient status. Despite past 
and ongoing efforts, ABCB6 transport and other possible physiological functions 
remain unknown. The current study explores ABCB6 regulation and the impact of 
ABCB6 expression on energy metabolism.       
 
 Specific Aim 1 tests the hypothesis that the loss of ABCB6 in vivo results in 
disrupted metabolic homeostasis. We utilized a whole-body Abcb6 knock out mouse 
to study the metabolic effects of ABCB6 loss. Specifically, we tracked body weight 
and food consumption from post-weaning to adulthood, analyzed lipid and glucose 
metabolic pathways, and determined the impact of these pathway disturbances on 
substrate utilization and energy expenditure.  
 
Specific Aim 2 tests the hypothesis that ABCB6 expression is driven by nutrient 
availability and ensuing changes of ABCB6 expression controls mitochondrial form 
and function in response to energetic state. To determine that alterations in 
mitochondrial dynamics were directly attributable to ABCB6 expressional changes, 
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we utilized a genetic model that allowed for temporal, tissue-specific control of 
ABCB6 expression. Under these conditions, we monitored mitochondrial form and 
function as well as hepatic metabolic functions and the impact of these changes on 
whole-body homeostasis.  
 
Specific Aim 3 tests the hypothesis that alteration of ABCB6 expression modifies the 
hepatic metabolome. We used hepatocyte-specific Abcb6 deficient and over 
expressing mice to study the resulting changes in liver metabolites in both high-

















2.2  Study Significance 
         We have established a model that consistently and predictably alters 
mitochondrial form and function. Therefore, it is possible to ascertain the impact of 
the disruption of mitochondrial dynamics throughout the entire lifespan, including 
development, in a whole-body or tissue-dependent manner. Additionally, these 
studies allowed progress toward understanding the possible in vivo role of ABCB6. 
More importantly, the outcome of this and future studies could direct therapies for a 
myriad of congenital metabolic pathologies as well as interventions for metabolic 
syndrome due to chronic over-nutrition. This model promises to further elucidate the 
interconnected feedback signals between energy supply and the physiological 
















     Our current study is the only one, to our knowledge that studies the impact of 
mitochondrial ABC transporter, ABCB6 on energy metabolism. Also, ours is the only 
model that allows for inducible, tissue-specific, alteration of ABCB6 in vivo.  
     We demonstrate that altered expression of a mitochondrial ABC transporter 
affects mitochondrial form and function. More specifically, Abcb6 deficiency or 
overexpression impairs nutrient-mediated fusion and fission responses in mice. This 
study highlights the connection between mitochondrial transporters, energy sensing 
processes, and mitochondrial dynamic bioenergetics which introduces a novel 
approach to understanding the regulation of metabolic flexibility. 
     The liver-specific studies described in this dissertation illustrate how disruption of 
hepatic mitochondrial form and function has a dramatic effect on overall energy 
utilization and balance. There are limited models describing how impaired 
mitochondrial dynamics within a single tissue affect whole-body homeostasis. 
Analysis of non-hepatic tissues in our liver-specific model will further elucidate 
organ-organ crosstalk in various energy states thereby expanding our knowledge of 
whole-body energy physiology.  
    Currently, our knowledge of the regulation of ABCB6 expression is extremely 

































     ABCB6 is a member of the ATP binding cassette superfamily of transport proteins 
that has been shown to play a role in heme biosynthesis. Here, we assess the effect of 
disrupting mouse ABCB6 in vivo and report on its unanticipated role in metabolic 
regulation and body-weight homeostasis. Abcb6 deficient mice show early signs of 
mature onset obesity, which is more severe in males than in females. Abcb6-deficient 
mice show accumulation of abdominal fat, hepatic steatosis, and high fasting plasma 
levels of insulin leading to glucose intolerance and insulin resistance. Gene expression 
analyses of liver and visceral white fat from Abcb6-deficient mice show deregulation of 
metabolic programs, including fatty acid, glucose metabolism and lipid signaling. 
Indirect calorimetry analysis of Abcb6 deficient mice before the onset of obesity show 
disturbances in energy expenditure and physical activity. We identify disturbances in 
mitochondrial form and function as key factors affected by Abcb6 deletion in the liver. 
These findings reveal a role for a mitochondrial ATP binding cassette protein in the 












     The ATP binding cassette (ABC) superfamily of active transporters is composed of 
many functionally diverse proteins (Dean et al., 2001a; Dean et al., 2001b). These 
proteins are fundamental to membrane transport of a broad variety of substrates 
including amino acids, lipids, lipopolysaccharides, inorganic ions, peptides, sugars, 
metals, drugs and proteins (Dean, 2009; Dean, et al., 2001a; Schmitz et al., 2000). 
These proteins utilize energy derived from the hydrolysis of ATP to `pump' substrate 
across the membrane against a concentration gradient. The ABC transporters not only 
move a variety of substrates into and out of the cell but are also involved in intracellular 
compartmental transport (Dean, et al., 2001a; Dean, et al., 2001b) and are often vital to 
the health and survival of the organism. 
     The ATP binding cassette transporter subfamily member B6 (ABCB6) gene encodes 
a membrane protein of 842 amino acids with a transmembrane domain (TMD) followed 
by a nucleotide binding domain (NBD) (Chavan et al., 2013; Krishnamurthy, et al., 
2006). Hydrophobicity and sequence homology analysis suggests that the TMD 
contains six transmembrane helices with the N and C termini located in the cytoplasm. 
The minimal functional unit has been suggested to be a homodimer residing in the outer 
mitochondrial membrane (Chavan, et al., 2013; Krishnamurthy, et al., 2006). ABCB6 
has been characterized as a mitochondrial transporter involved in the translocation of 
coproporphyrinogen III (CPIII) from the cytoplasm into the mitochondria (Chavan, et al., 
2013; Krishnamurthy, et al., 2006). CPIII a byproduct of heme synthesis in the 
cytoplasm requires active transport into the mitochondria to complete heme synthesis 
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(Krishnamurthy et al., 2007). Thus, ABCB6 has been characterized with a physiological 
role in heme synthesis.  
     Recent localization and genome association studies have suggested that 
mammalian Abcb6 has several other functions and localization. ABCB6 has been 
localized to the plasma membrane and specifies the new blood group system Langereis 
(Lan) (Helias, et al., 2012). Loss of ABCB6 function has been associated with 
developmental defects including ocular coloboma (Wang, et al., 2012). Further, 
exogenous expression of ABCB6 has been correlated with increased cell growth and 
proliferation while loss of ABCB6 expression results in delayed progression through the 
mitotic phase of the cell cycle (Polireddy et al., 2011). These studies together suggest 
that ABCB6 might have non-heme functions in mammals.  
     To test the role of ABCB6 in vivo, we have analyzed the phenotypes associated with 
ABCB6 loss. Here, we report on an unanticipated function of ABCB6 in controlling body 
weight and regulating metabolism. Abcb6 knockout mice display a phenotype 
characterized by obesity, glucose intolerance, insulin resistance, liver steatosis and 
adipose tissue expansion. Dysregulated hepatic function and adipose tissue expansion 
coincide with significant alterations in gene expression and are preceded by significant 
alteration in daily energy expenditure and physical activity. Lastly, we identify that in 








Mature-onset obesity in mice lacking ABCB6 
 
     To study the physiological function of ABCB6 in vivo we generated a whole-body 
constitutive Abcb6 knockout mouse by homologous recombination. As we previously 
reported, mice lacking ABCB6 show a pleiotropic phenotype including embryonic 
lethality and short stature (Chavan, et al., 2015). However, a subset of Abcb6 knockout 
mice were alive and fertile (Chavan, et al., 2015). Surprisingly, Abcb6-KO mice that 
survived embryonic lethality and overcame short stature, displayed a gradual increase 
in body weight. To establish a chronology of overweight occurrence in the absence of 
ABCB6, we performed regular weight and food consumption recordings of individual 
mice under a standard diet over a 20-week period. By 20 weeks of age Abcb6 deficient 
male mice showed a significant increase in body weight (Figure 1A-1C, right panel; 16% 
increase over WT males). In contrast to male mice, the difference in body weight among 
females was less pronounced (Figure 1A-1C, left panels; 6% increase over WT 
females). The increase in body weight in either male or female mice could not be 
attributed to increase in food intake (Figures 1D and 1E). Together, these findings 
indicate that ABCB6 deletion leads to early signs of mature-onset obesity, which is more 
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Figure 3.1 Abc6 deficiency leads to early signs of mature onset obesity 
(A) Abcb6-KO male mice display morphological signs of obesity when compared to Abcb6-WT 
controls. Shown are representative photographs of 20-week old male (left) and female (right) 
mice. (B) Body weight curves of Abcb6-WT and Abcb6-KO mice over a period of 20 weeks. (C) 
Animals were fed a normal chow diet and weighed once every week. Data represent mean 
value ± SD Statistical significance was determined by two-tailed Student’s t test. ap < 0.05 
Individual value plot showing the actual weight of each mice at 20 weeks of age. 15 mice per 
genotype. (D) Relative food intake curves per mice per week. Data represent mean value ± SD. 
(E) Individual value plot showing the relative food intake per mice at 20 weeks. Data represent 
mean value ± SD.  
 
Abcb6-deficient mice accumulate more fat in visceral tissues and show signs of 
liver steatosis 
 
     We next determined whether increased body weight in Abcb6-deficient mice could 
be attributed to a difference in body composition. To this end we performed ECHOMRI 
which allows quantification of whole-body fat mass and the fat-to-lean ratio. We found 
that Abcb6 deficient mice had a significant relative increase in fat mass and a 
statistically non-significant decrease in lean mass (Figure 3.2A) at 20 weeks of age.    
We next examined if the larger fat mass of Abcb6 deficient mice reflects a proportionate 
increase in organ size. Direct measurements of organ weights from mice maintained on 
standard diet showed a significant increase in liver, intraabdominal fat, and brown fat 
mass relative to total body weight in Abcb6-deficient male mice compared to wild-type 
controls (Figures 3.2B). The gross morphology of liver, intrabdominal fat and brown fat 
was consistent with the increased mass of these tissues in Abcb6-deficient male mice 
(Figures 3.2C). Further, no significant differences in the weight of spleen, and kidney 
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was observed in either the male or the female Abcb6 deficient mice compared to their 
respective controls (data not shown). Hematoxylin and eosin staining (H&E) of liver and 
white fat sections revealed increased hepatic lipid deposits and a larger size of 
adipocytes (Figure 3.2D) in Abcb6 deficient mice. Oil red O staining of liver sections 
confirmed accumulation of large lipid droplets suggestive of liver steatosis 
(Figure 3.2D). The oil red O-stained area per section was significantly higher in Abcb6-
deficient mouse livers compared to wild-type controls (Figure 3.2E). Finally, we found 
increased amounts of liver triglycerides in Abcb6-deficient mice compared to wild-type 
controls, further indicative of liver steatosis (Figure 3.2F). The increased adiposity in 
Abcb6 deficient mice was consistent with decreased adipocyte number (Figure 3.2G). 
Interestingly, the increased adiposity in Abcb6 deficient mice was not associated with 
inflammation, because we did not find any difference in F4/80 staining of white fat 
sections in Abcb6-deficient samples compared to the wild-type controls (Figure 3.2H).  
Of note, we observed accumulation of white fat also around brown fat in Abcb6-deficient 
mice, which was coincidental with larger intracellular lipid droplets in brown fat tissues 
(Figures 3.2C).      
 
Abcb6-deficient mice are glucose resistant and show some signs of metabolic 
syndrome 
    In humans, increased body mass and fatty liver are indicative of metabolic defects, a 
condition associated with glucose intolerance and insulin resistance (Castro et al., 2014; 
Moller et al., 2005). To address whether Abcb6-deficiency lead to features of glucose 
intolerance and insulin insensitivity, we tested the ability of Abcb6-deficient mice to 
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respond to glucose and insulin. To this end, we performed glucose and insulin tolerance 
tests (GTTs and ITTs, respectively) on 20-week-old mice. Although blood glucose, 
taken after an overnight fast, was not significantly different between the genotypes, a 
small but significant increase in higher values of glucose were observed in Abcb6-
deficient mice after an intraperitoneal glucose tolerance test (Figure 3.2I). In contrast to 
blood glucose levels Abcb6 deficient mice showed a small but significant increase in 
serum insulin levels (Figure 3.2J). The presence of greater insulin resistance in the 
Abcb6 deficient mice was confirmed by the insulin tolerance test; at a dose of 0.75 U/kg, 
the Abcb6 deficient mice showed a small but significantly lower decrease in blood 
glucose (Figure3.2J). The area under the curve (AUC) values for the GTT and ITT 
assays were significantly higher in Abcb6-deficient mice compared to wild-type controls 













































































Figure 3.2 Abcb6-Deficient male mice accumulate more fat and are insulin resistant  
(A) Relative fat mass and lean mass of 20-week-old male mice n=15 mice per genotype 
(B) Organ weight-to-total body weight ratios, WAT, White adipose tissue; BAT, brown adipose 
tissue, n = 15 mice per genotype (C) Representative macroscopic images of the indicated 
tissues and organs (D) Representative light microscopy images of H&E sections, and oil red O 
staining of the indicated tissues, WAT, white adipose tissue; BAT, brown adipose tissue (E) 
Quantification of oil red O-positive areas in liver sections of the indicated genotypes (F) 
Quantification of triglyceride content in liver samples, n=15 mice per genotype (G) Quantification 
of the adipocyte number in abdominal fat depots (H) Average macrophage count per high power 
field [HPF (200x optical field)]. Ten adjacent HPF were used and the average number of positive 
cells per HPF was calculated. (I) Fasting glucose levels and GTT data of fifteen 20-week-old 
wild-type and Abcb6 knockout mice (J) Fasting inulin and ITT data of fifteen 20-week-old wild-




(AUC), a.u., arbitrary units Values represent means ± SD. Statistical significance was 
determined by two-tailed Student’s t test. ap < 0.05, abp< 0.01 
Abcb6-deficient mice show altered hepatic and adipose gene expression that 
favor the altered hepatic and adipose phenotype 
     To investigate the biological processes underlying the altered hepatic and adipose 
phenotype, we assessed the effects of Abcb6 deficiency on gene transcription and 
protein translation in liver and adipose of 20-week-old mice. We focused our attention 
on liver first, due to its role in regulating metabolic homeostasis. We used an Affymetrix 
GeneChip microarray to assess gene expression changes. Of the total 45,105 
transcripts analyzed 501 genes were differentially expressed between Abcb6-WT and 
Abcb6-deficient mice (p< 0.05 with a fold change > 1.5; 336 downregulated and 165 
upregulated genes). Ingenuity Pathway analysis of all differentially expressed genes 
indicated a significant dysregulation in genes which impact different metabolic pathways 
including lipid, fatty acid, cholesterol and carbohydrate metabolism as well as in genes 
involved in developmental process, organismal survival, reproduction and transport 
(Figure 3.3A pie diagram to the left). To confirm and extend the GeneChip results 
further we examined liver mRNA and protein response focusing on protein products 
related to fatty acid and lipid metabolism. Consistent with the microarray data we found 
a modest but significant difference in the expression of mRNA and protein that regulate 
hepatic fat and lipid homeostasis in the livers of Abcb6 deficient mice compared to wild 
type control mice (Figure 3.3B & 3.3C). Quantification of the protein bands in the 
immunoblots allowed confirmation of the presence of significant differences in the 




     We next turned our attention to the intra-abdominal fat. Differential gene expression 
analysis, using the PRIMEPCR pathway analysis plate (BioRad), revealed 62 genes 
that were significantly deregulated in Abcb6 deficient male mice as compared to age-
matched controls. Ingenuity Pathway analysis of all differentially expressed genes 
indicated a significant deregulation in genes involved in regulating metabolic process, 
including fat and lipid metabolism (Figure 3.3A pie diagram to the right). To confirm and 
extend the microarray expression analysis we examined the intrabdominal mRNA and 
protein response focusing on protein products related to fatty acid and lipid metabolism. 
As observed in the liver protein response, we found a modest but significant difference 
in the expression proteins that regulate adipose fat and lipid homeostasis in Abcb6 
deficient mice compared to wild type control mice (Figure 3.3D & 3.3E). Quantification 
of the protein bands in the immunoblots allowed confirmation of the presence of 
significant differences in the expression of proteins involved in adipose fat and lipid 















































































Figure 3.3 Abcb6 Deficiency alters liver and adipose metabolism leading to steatosis and 
adipose expansion respectively 
(A) Gene ontology analysis and classification of differentially expressed genes into biological 
processes. (B) qPCR and western blot validation of selected mRNA and proteins involved in fat 
mobilization. Gene expression changes were normalized to actin and fold changes were 
normalized to Abcb6-WT mice. (C) qPCR and western blot validation of selected mRNA and 
proteins involved in de-novo lipogenesis. (D) Western blot validation of selected proteins 
involved in adipose tissue lipolysis. (E) Western blot validation of selected proteins involved in 
adipose tissue lipid homeostasis. Values represent mean ± SD. Statistical significance was 
determined by two-tailed Student’s t test. ap < 0.05, abp< 0.01 ImageJ was used to normalize 





Abcb6 deficient mice have decreased energy expenditure and physical activity. 
 
     We next sought to define the basis for the altered body composition in the Abcb6 
deficient mice. To this end, we performed indirect calorimetry analysis to determine 
whether increased body weight in Abcb6 deficient mice could be due to differences in 
energy expenditure (EE). Cohorts of male mice at 6 weeks of age, prior to when the 
effect of Abcb6 deletion on body weight is evident, were placed on a standard diet and 
subjected to indirect calorimetry analysis. We found significant differences in both day 
and night time EE in Abcb6 deficient male mice (Figures 3.4A & 3.4I). We also found 
significant differences in VO2 and VCO2 between the genotypes (Figures 3.4B & 3.4C 
and 3.4J & 3.4K). More importantly we observed lower respiratory exchange rate (RQ) 
in Abcb6-deficient males compared to wild-type males in both light and dark cycles 
(Figures 3.4D & 3.4L). Finally, measurements of physical activity taken during the 
calorimetry studies revealed a modest but significantly decreased nighttime but not 
daytime locomotor activity in Abcb6 deficient male mice compared to wild-type mice 
(Figure 3.4E & 3.4F and 3.4M & 3.4N). Together, these results suggest that the 
substantially increased deposition of fat in Abcb6 deficient mice could be partly 

















































































Figure 3.4 Abcb6 Deficiency affects diurnal energy expenditure  
(A-D) Average daytime (A) energy expenditure, (B) volume of O2, (C) volume of   CO2, and (D) 
RER (E-F) Average daytime (E) activity, (F) distance travelled, (G) average food intake and (H) 
average water intake. (I-L) Average nighttime (I) energy expenditure, (J) volume of O2, (K) 
volume of CO2, and (L) RER. (M-P) Average nighttime (M) activity, (N) distance travelled, (O) 
average food intake and (P) average water intake. Indirect calorimetric analysis of 6 – week-old 
Abcb6-WT and Abcb6-KO mice monitored during a week period in metabolic cages. Values 




High-fat diet further aggravates obesity and diabetes in Abcb6-deficient mice 
To further understand the origin of obesity and liver steatosis associated 
with Abcb6 deficiency, we subjected 6-week-old Abcb6+/+ and Abcb6−/− mice to high-fat 
diet (HFD) and followed weight gain in a longitudinal manner (weekly measurements). 
HFD resulted in a significant increase in body weight compared to wild-type controls, 
(Figure 3.5A and 3.5B). The increased body weight of Abcb6 deficient mice fed a HFD 
could not be attributed to differences in daily food intake (Figure 3.5B inset). 
     Next, we performed direct measurements of organ weights from mice maintained on 
HFD. We observed a significant increase in liver, intra-abdominal, and brown fat mass 
(Figure 3.5D & 3.5E) relative to total body weight in Abcb6-deficient mice compared to 
wild-type controls on HFD. Hematoxylin and eosin staining (H&E) of white fat revealed a 
larger size of adipocytes in Abcb6 deficient mice (Figure 3.5F). Oil red O staining of liver 
sections confirmed accumulation of large lipid droplets (Figure 3.5F). Finally, we found 
increased amounts of liver triglycerides in Abcb6-deficient mice (Figure 3.5I). Of note, 
we observed accumulation of white fat also around brown fat in Abcb6-deficient mice, 
which was coincidental with larger intracellular lipid droplets in brown fat tissues 
(Figures 3.5F).  
     To further understand the metabolic effects of HFD in Abcb6 deficiency, we analyzed 
several metabolic parameters in the plasma of mice of both genotypes. Glucose and 
insulin plasma levels were increased in Abcb6 deficient mice (Figure 3.5C). The GTTs 
and ITTs confirmed that Abcb6-deficient mice are significantly more glucose resistant 
and insulin-insensitive than wild-type mice on the same diet (Figure 3.5G and 3.5H). We 
also found that the levels of cholesterol, serum triglycerides and free fatty acids were 
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elevated in Abcb6 deficient mice compared to their wild type counterparts (Figures3. 5I 
– 3.5M). Taken together, these results suggest that ABCB6 impairment has adverse 







































































































































Figure 3.5 Enhanced weight gain and disruption of glucose metabolism in Abcb6     
deficient mice subjected to HFD 
(A) Representative image of male mice of the indicated genotype and age subjected to HFD for 
8 weeks. (B) Weight curves of male mice of the indicated genotype on HFD (60% calories from 
fat) commencing at 5 weeks of age. Inset in (B) relative food intake monitored during the HFD 
feeding. (C)  Fasting glucose and insulin levels in male mice of the indicated genotype. (D) 
Representative macroscopic images of the indicated tissues and organs. (E) Organ weight-to-
total body weight ratios, WAT, White adipose tissue; BAT, brown adipose tissue, n = 15 mice 
per genotype. (F) Representative light microscopy images of H&E sections, and oil red O 
staining of the indicated tissues, WAT, white adipose tissue; BAT, brown adipose tissue. (G) 
Glucose tolerance test (GTT) data in Abcb6-WT and Abcb6-KO mouse fed HFD for 8 weeks. 
(H) Insulin tolerance test (ITT) data in Abcb6-WT and Abcb6-KO mice fed HFD for 8 weeks. 
(I-M) Analysis of hepatic and plasma parameters in wild-type and Abcb6-deficient mice on HFD. 
(I) Hepatic TG, (J) Plasma LDL/VLDL ratio, (K) Plasma TG, (L) Plasma HDL (M) Plasma FFA. 
TG, Triglycerides; LDL, low density lipoproteins; VLDL, very low-density lipoproteins, HDL, high 
density lipoprotein; FFA, free fatty acids.  
Values represent mean ± SD. Statistical significance was determined by two-tailed Student’s t 
test. ap < 0.05, abp < 0.01 
 
ABCB6 expression is suppressed under obese conditions 
     Given the significant association between Abcb6 deficiency, and obesity we 
wondered if ABCB6 expression is differentially regulated under obese conditions. To 
test this hypothesis, we extracted proteins from livers and intra-abdominal adipose 
tissue of HFD induced obese mice and mice that are obese because of leptin deficiency 
(ob/ob). We found that ABCB6 expression was suppressed in the livers and white 
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adipose tissue of both HFD induced obese mice and leptin deficient obese mice 
(Figures 3.6A and 3.6B). We next sought to extend these observations and test whether 
ABCB6 expression was differentially regulated in obese humans compared to their ‘non-
obese’ counterparts. Towards this end we analyzed ABCB6 expression in clinically 
obese (BMI≥ 30, with hepatic steatosis of 20% or more by histology) and non-obese 
(BMI≤ 25, with no significant steatosis) human livers. As observed in the livers of obese 
mice we found decreased ABCB6 expression in obese human livers (Figure 3.6C). 
Together these results suggest a strong association between ABCB6 expression and 





























Figure 3.6 Conditions that lead to obesity affects ABCB6 expression in liver and adipose 
tissue  
(A) Representative figure showing the effects of HFD feeding on ABCB6 abundance in liver 
(upper left) and adipose tissue (upper right).  (Lower panels) Quantification of the protein bands 
in the immunoblots normalized to actin (n=15 mice per genotype). (B) Representative figure 





(ob/ob) mice. (Lower panels) Quantification of the protein bands in the immunoblots normalized 
to actin (n=15 mice per genotype). (C) Representative figure showing hepatic ABCB6 
expression in obese (BMI≥ 30, with hepatic steatosis of 20% or more by histology) and non-
obese (BMI≤ 25, with no significant steatosis) human. Values represent mean ± SD. Statistical 
significance was determined by two-tailed Student’s t test. ap < 0.05. 
 
Abcb6 deficient mice display altered mitochondrial form and function 
     Over the past decade, it has become evident that shifts in energy expenditure are 
often linked to changes in mitochondrial function and such altered mitochondrial 
function also underlie systemic metabolic abnormalities that characterize the many 
clinical features of metabolic disease (Kim et al., 2008; Krishnamurthy, et al., 2011; 
Pintus et al., 2012). Given that ABCB6 is a mitochondrial protein we wondered if some 
of the observed phenotype in Abcb6 deficiency could result from altered mitochondrial 
function. To test this, we evaluated liver mitochondrial morphology and liver 
mitochondrial function in 6-week-old Abcb6-deficient male and female mice, prior to 
when the effect of Abcb6 deletion on body weight is evident. We found loss of ABCB6 
resulted in swollen mitochondria with indistinct cristae in liver tissue (Figure 3.7A and 
3.7B left panels) and decreased mitochondrial function in primary hepatocytes (Figure 
3.7A and 3.7B middle panels) and crude mitochondria isolated from Abcb6-deficient 
livers (Figure 3.7A and 3.7B right panels). Interestingly, we found that the mitochondrial 
form and function changes observed in Abcb6-deficient mice livers on standard chow 
diet was analogous to those observed in wildtype mice that developed obesity in 
response to high-fat diet feeding (Figure 3.7D) or developed obesity because of leptin 
deficiency (ob/ob mice; Figure 3.7C). Together, these results suggest a strong 
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association between ABCB6 expression and mitochondrial form and function in obesity 
linked metabolic disease. 
     The oxidative phosphorylation system, consisting of the four-multimeric enzyme 
complexes (CI–CIV) of the respiratory chain, and the ATP synthase complex (CV), drive 
the synthesis of ATP in most cells and defines the bioenergetic efficiency of the 
mitochondria. We wondered whether altered expression and/or activity of oxidative 
phosphorylation complexes contributed to the differential bioenergetic capacity of the 
hepatic mitochondria in Abcb6 deficient mice. To test this, we measured the activity of 
each (CI, CII, CIII, and CIV) of the respiratory complexes and found a significant 
decrease in the activity of CI, CIII and CIV complexes in Abcb6 deficient mice (Figure 
3.7E left panel). We next determined if the changes in enzyme activity resulted from 
changes in respiratory complex expression. Towards this end we performed a 
denaturing gel electrophoresis of mitochondrial proteins isolated from Abcb6-
deficienand Abcb6 WT control mice liver. Surprisingly, western blot analysis revealed no 
significant difference in the protein levels of any of the complexes in Abcb6-deficient 
mice compared to the Abcb6WT controls (Figure 3.7E middle panel). Quantification of 
the protein bands in the immunoblots allowed confirmation of the lack of significant 
differences in the expression of respiratory complexes between the Abcb6 genotypes 
(Figure 3.7E right panel). Together these results suggest that the decreased hepatic 
mitochondrial bioenergetics in Abcb6 deficiency could partly arise from a decrease in 
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Figure 3.7 continued 
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Figure 3.7 ABCB6 expression affects hepatic bioenergetic capacity 
(A) Representative electron microscopic image showing the effects of Abcb6 deficiency on   
hepatic mitochondrial morphology, primary hepatocyte bioenergetics and isolated mitochondrial 
bioenergetics in 6-week-old Abcb6-WT and Abcb6-KO male mice. (B) Representative electron 
microscopic image showing the effects of Abcb6 deficiency on hepatic mitochondrial 
morphology, primary hepatocyte bioenergetics, and isolated mitochondrial bioenergetics in 6-
week-old ABCB6-WT and Abcb6-KO female mice. (C) Representative electron microscopic 
image showing the effects of obesity on hepatic mitochondrial morphology and isolated 
mitochondrial bioenergetics in 8 -week-old leptin deficient ob/ob mice fed a standard chow diet. 
(D) Representative electron microscopic image showing the effects of diet induced obesity on 
hepatic mitochondrial morphology and isolated mitochondrial bioenergetics in mice fed HFD for 
8 weeks. (E) Quantification of OXPHOS complex activity and expression in Abcb6 deficient 
mice at 6 weeks of age.   
3.4 Discussion 
     Overall our study sheds light on a yet unanticipated role for mammalian ABCB6 in 
normal body weight control. Our data establish that ABCB6 acts as a molecular 
determinant of metabolic homeostasis. Abcb6 deficiency leads to a multisystem 
metabolic derangement reflected by glucose intolerance, insulin resistance, liver 
steatosis, and excess fat accumulation. Ultimately, this manifests as late onset obesity 
in the Abcb6 knockout mice.  
     Although the mechanism underlying the metabolic phenotype of Abcb6 deficiency 
remains to be delineated, our observation draws an interesting link between 
mitochondrial transport, mitochondrial function, metabolic flexibility and metabolic 
regulation. The best explanation we could identify for the differential gain in fat mass in 
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Abcb6-deficient mice is decreased EE as measured by indirect calorimetry. Regarding 
the source of the decreased EE in Abcb6 deficient mice, the altered mitochondrial form 
and function observed in Abcb6 deficiency provides an important clue, particularly given 
that these alterations in mitochondrial form and function as well as decreased EE occur 
simultaneously and prior to when the effect of Abcb6 deletion on body weight is evident.  
     A number of studies have described reduced levels of mRNA for mitochondrial 
genes (Heilbronn et al., 2007; Mootha et al., 2003; Morino et al., 2005; Patti et al., 
2003), decreased mitochondria DNA (Boushel et al., 2007; Ritov et al., 2005) and lower 
protein expression of respiratory chain subunits (Heilbronn, et al., 2007) in mitochondria 
isolated from insulin-resistant individuals. However, several features point to a more 
complex role for ABCB6 in mitochondrial bioenergetics and mitochondrial function. 
These include the decreased activity of the mitochondrial respiratory complexes without 
any change in the either the transcriptional or translational efficiency of many liver 
mRNAs encoding mitochondrial electron transport components. We speculate that 
change in mitochondrial form observed in Abcb6 deficiency might be a contributing 
factor for decreased mitochondrial function. Such a functional change would be 
analogous to the Barth syndrome, a fatal X-linked recessive disease characterized by 
cardioskeletal myopathy (Barth et al., 2004), where defective mitochondrial form 
correlates with reduced mitochondrial bioenergetics leading to severe cellular 
dysfunction (McKenzie et al., 2006). Alterations in mitochondrial form have also been 
identified during aging (Frenzel et al., 2010; Lombardi et al., 2009; Lopez-Lluch et al., 
2015), as well as in metabolic disease (Arruda et al., 2014) including type 2 diabetes 
(Antoun et al., 2015).  
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     Obesity is a major global public health concern that has now reached epidemic 
proportions. Obese individuals are faced with a markedly increased risk of 
cardiovascular disease, type 2 diabetes, osteoarthritis, and several metabolic 
syndromes. Of the many genes that have been reported to impact obesity in mice, only 
a handful of heritable genes have been identified in human genetic studies. Results 
from our studies suggest that ABCB6 expression correlates inversely with body weight 
gain. Although, gene association studies have established a strong link between loss of 
ABCB6 function with a variety of human diseases (Chavan, et al., 2015; Cui et al., 2013; 
Wang, et al., 2012; Zhang, et al., 2013), it remains to be seen whether such loss of 
function mutations in ABCB6 are also associated with human metabolic syndromes. 
Nevertheless, our finding that ABCB6 expression is down regulated in obese conditions, 
and loss of ABCB6 results in weight gain, and substantial metabolic phenotype supports 
the case for Abcb6 as a causal gene in metabolic disease and provides a strong 
impetus to the investigation of the physiologic roles of the human Abcb6 SNPs in 
metabolic disease.  
     In conclusion, our studies demonstrate that Abcb6 deficient mice, both male and 
female, present impaired hepatic mitochondrial function and are susceptible to diet 
induced obesity, glucose intolerance, hepatic steatosis and adipose tissue expansion. 
Given that ABCB6 is ubiquitously expressed and that loss of ABCB6 results in a wide 
variety of human pathologies, it will be important to evaluate if ABCB6 has tissue 





























     Hepatic mitochondria undergo cyclical changes in their shape, size, and distribution to 
adapt their bioenergetic and biosynthetic output to the ever-changing anabolic/catabolic 
state of the liver. This adaptability allows organisms to switch freely between alternative 
fuels, according to physiological and nutritional circumstances, and is essential to 
maintain metabolic homeostasis.  Here we provide evidence that the mitochondrial outer-
membrane protein ABCB6 plays a pivotal role, in controlling systemic energy and body 
weight homeostasis, through temporal regulation of mitochondrial dynamics. In mice 
ABCB6 expression is in sync-with diurnal bioenergetic demands, and chronic loss or gain 
of hepatic ABCB6 results in lack of bioenergetic and biosynthetic adaptation of the 
mitochondria, leading to metabolic inflexibility and the development of metabolic disease. 
Our data suggest that ABCB6 acts as a conserved pivot for the adaptive metabolic 
responses to promote the bioenergetic and biosynthetic adaptation of the mitochondria, 













     Organisms sense nutrients in the environment and adapt their metabolism based on 
the available energy. This adaptability, termed ‘metabolic flexibility’, allows organisms the 
ability to switch from fatty acid oxidation during the fasted state to enhanced glucose 
metabolism during the fed state (Kohler, 1985) (Gao et al., 2014; Smith et al., 2018b). 
During the last decade, mitochondria have independently emerged as key regulators of 
metabolic flexibility (Gao, et al., 2014; Liesa et al., 2013; Stephenson et al., 2014).  
Mitochondrion’s ability to regulate cellular processes such as ATP synthesis, 
autophagy/mitophagy, and apoptosis in response to changing energetic levels maintains 
metabolic homeostasis. Dysregulation in mitochondrial function has been shown to result 
in metabolic inflexibility leading to the inability of the organism to adapt its metabolism to 
energetic changes, resulting in the development of metabolic diseases such as obesity 
and insulin resistance (Corpeleijn et al., 2009; Galgani et al., 2008; Gao, et al., 2014; 
Smith, et al., 2018b).  
     Two main mechanisms allow mitochondria to adjust ATP synthesis to changes in 
energetic demand and to control metabolic flexibility (i) acute change of both 
mitochondrial dynamics (fusion and fission) and post-translational modifications, and (ii) 
longer-term modification of mitochondrial quantity.(Gao, et al., 2014). Evidence 
suggests that mitochondrial response to nutrients is mediated by the acute change; 
mitochondrial dynamics, which is shaped by fusion and fission (Gao, et al., 2014). In 
nutrient excess, cells maintain their mitochondria in a fragmented state, while during 
fasting/starvation mitochondria tend to persist in a fused state (Gomes et al., 2011a; 
Liesa, et al., 2013; Molina et al., 2009). While the complete lack of fusion or fission 
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results in embryonic lethality (Chen et al., 2003; Davies et al., 2007; Ishihara et al., 
2009), shifts in balance between fusion and fission are an important adaptive process 
required to retain mitochondrial flexibility and health upon changes to our environment 
(Kulkarni et al., 2016; Sebastian et al., 2012; Wang et al., 2015). However, our 
understanding of the potential mechanisms that regulate the dynamic shifts in fusion 
and fission, to remodel mitochondrial architecture upon whole-body physiology remain 
largely incomplete. 
     In this report, we show that ABCB6, a mitochondrial outer membrane ATP binding 
cassette protein, is an important regulator of mitochondrial form and function in the liver. 
Loss of ABCB6 in hepatocytes leads to a pronounced shortcoming in mitochondrial 
morphology that favors fission. In contrast liver-specific overexpression of ABCB6 
favors fusion which results in elongated mitochondria. In addition, we find that ABCB6 
expression is in sync-with diurnal bioenergetic demands, and that chronic loss or gain of 
ABCB6 results in lack of biosynthetic adaptation of the mitochondria to the changing 
anabolic/catabolic state of the liver leading to metabolic inflexibility. Although, the exact 
mechanism by which ABCB6 regulates mitochondrial dynamics and metabolic 
homeostasis is not completely clear, the strength of evidence presented in this report 
favors the hypothesis that ABCB6 is a potential regulator of mitochondrial form and 
function and suggests a role for ABCB6 in linking environmental stimuli to mitochondrial 








Genetically engineered hepatic ABCB6 deficient mice exhibit altered mitochondrial 
form. 
     We used adeno associated viral delivery of Cre-recombinase, driven by liver specific 
Thyroxine- binding globulin (TBG) promoter, to eliminate hepatic ABCB6 expression 
postnatally (Figure 4.1A). This approach eliminated ABCB6 expression by > 85% ten days 
post infection (Figure 4.1B). In the rest of this dissertation, liver specific ABCB6 deficient 
mice are designated by the acronym Abcb6LKO, liver-specific overexpressing mice by 
Abcb6LOE, and Abcb6 wild-type control mice are designated by the acronym Abcb6WT. 
     Although, ABCB6 has been shown to regulate heme synthesis in vitro (Krishnamurthy, 
et al., 2006), loss of ABCB6 in the present mouse model did not affect hepatic heme 
levels (Figure 4.1C), nor were there any compensatory responses in the expression of 
heme synthesis pathway genes (Figure 4.1D). However, quite surprisingly, mice with 
liver-specific deletion of ABCB6 (Figures 4.1E-1G) displayed a shift in mitochondria size 
distribution, toward rounder, shorter organelles, compared to wild-type littermate controls 
(Abcb6WT) (Figure 4.1H). We performed a systematic evaluation of these mitochondrial 
alterations and found an overall increase (~26%) in the mitochondrial number in 
Abcb6LKO mice (338 in Abcb6LKO vs 269 in Abcb6WT mice per image of 980 µm2; 
(Figure 4.1I). However, we found that on an average the area of the individual 
mitochondrion decreased by ~16% in Abcb6LKO mice (0.606 µm2 in Abcb6LKO livers vs 
0.724 µm2 in Abcb6WT livers; (Figure 1K) without any significant difference in the total 
mitochondrial area between the two groups of animals (Figure 4.1J). We found that this 
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change in decreased mitochondrion area in Abcb6LKO mice was due to a shift in 
mitochondria size distribution toward rounder (Figure 4.1H), shorter organelles (Figure 





































































Figure 4.1 continued 
 
Figure 4.1 Loss of hepatic ABCB6 is linked to fragmentation of the mitochondrial network 
(A) Schematic representation of the generation of tissue specific Abcb6 knockout mice using the 
Cre-loxP system. The floxed Abcb6 gene mouse line contains loxP sites flanking exon 2. 
Injection of AAV8 viral particles carrying the Cre-recombinase under the control of liver specific 
(TBG) promoter deletes the intervening DNA sequence resulting in loss of exon 2. (B) 
Immunoblot analysis of ABCB6 expression in Abcb6-floxed mice injected with AAV8-TBG-PI. 
Cre. (C) Hepatic heme levels in Abcb6WT, Abcb6LKO, and Abcb6LOE mice. (D) RTPCR 
analysis of hepatic enzymes involved in heme biosynthesis in Abcb6WT and Abcb6LKO mice. 
Histograms represent mean ± SD.  
 (E) Representative western blot analysis of ABCB6 and Porin in Abcb6LKO and Abcb6WT mice 
at 10 days post infection. Porin is used as a loading control. (F) ImageJ analysis of protein bands 
normalized to porin. Average of three independent studies with 5 mice per group per study. 
Histograms are mean ± SD (G) RTPCR analysis of Abcb6 transcript levels in Abcb6LKO and 
Abcb6WT mice. Average of three independent studies with 5 mice per group per study. 
Histograms are mean ± SD (H) Representative EM image of liver mitochondria used to study 




average mitochondria number per image, (J) average mitochondria area per image, (K) average 
area per mitochondrion, (L) mitochondria shape, (M) mitochondria number major axis class 
distribution, (N) mitochondria percent major axis class distribution. Mitochondrial network 
dynamics were calculated in 16 images (2 images per mice per genotype) each of 980 µm2 
representing 8 Abcb6LKO and 8 Abcb6WT mice. Values represent mean ± SD. 
Genetically engineered hepatic ABCB6 overexpressing mice exhibit altered 
mitochondrial form  
     We next tested whether ectopic overexpression of ABCB6 in wildtype mice would 
affect mitochondrial morphology. We used adenoviral associated viral delivery of Abcb6 
gene, driven by liver specific TBG-promoter to ectopically express ABCB6 in the livers of 
Abcb6WT mice. This delivery method resulted in a ~ 4-fold increase in ABCB6 expression 
in the livers of Abcb6WT mice by 10 days post infection (Figure 4.2A-4.2C). In the rest of 
the dissertation liver specific ABCB6 overexpressing mice are designated by the acronym 
Abcb6LOE. 
     We found that ectopic overexpression of ABCB6 resulted in mitochondria that were 
significantly more elongated than those observed in Abcb6WT mice that received control 
AAV particles (Figure 4.2D). A systematic evaluation of these mitochondrial alterations 
demonstrated an overall decrease (~ 18%) in the mitochondrial number (174 Abcb6LOE 
mice vs 266 in Abcb6WT mice per image of 980 µm2; Figure 4.2E), and an overall 
increase in the area of the individual mitochondrion in Abcb6LOE mice (1.191 µm2 in 
Abcb6LOE livers vs 0.782 µm2 in Abcb6WT livers; Figure 4.2G). However, we did not find 
any significant difference in the total mitochondrial area between the two groups of 
animals (Figure 4.2F). As with the Abcb6LKO mice the change in individual mitochondrion 
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area and number in Abcb6LOE mice appear to result from a shift in mitochondria size 
distribution toward longer, elongated organelles (Figures 4.2H – 4.2J). Together these 




















































Figure 4.2 Overexpression of hepatic ABCB6 is linked to hyper-fusion of the 
mitochondrial network  
(A) Representative western blot analysis of ABCB6 and Porin in Abcb6LOE and Abcb6WT mice. 
Porin is used as a loading control. (B) ImageJ analysis of protein bands normalized to porin. 





SD (C) RTPCR analysis of Abcb6 transcript levels in Abcb6LOE and Abcb6WT mice. Average of 
three independent studies with 5 mice per group per study. Histograms are mean ± SD. (D) 
Representative EM image of liver mitochondria used to study mitochondrial number, area and 
morphology. (E-J) Effect of ABCB6 overexpression on (E) average mitochondria number, (F) 
average mitochondria area per image, (G) average area per mitochondrion, (H) mitochondria 
shape, (I) mitochondria number major axis class distribution, (J) mitochondria percent major axis 
class distribution. Mitochondrial network dynamics were calculated in 12 images (2 images per 
mice per genotype) each of 980 µm2 representing 6 Abcb6LOE and 6 Abcb6WT mice. Values 
represent mean ± SD. 
Altered mitochondrial form in genetically engineered hepatic Abcb6 deficient and 
Abcb6 overexpressing mice results in altered mitochondrial function 
     Mitochondrial architecture, through the balance between fusion and fission events, 
represents a central mechanism for bioenergetic adaption (Cheng et al., 2013; Liesa, et 
al., 2013; Nasrallah et al., 2014). In general, elongated mitochondria (fusion) are 
considered to be in a state of increased bioenergetic efficiency, while in contrast 
shortened mitochondria (fission) are considered to be in a state of decreased 
bioenergetic efficiency (Liesa, et al., 2013). We hypothesized that increased 
mitochondrial elongation following ABCB6 overexpression would favor increased 
bioenergetic efficiency, while increased mitochondrial shortening in ABCB6 deficiency 
might favor decreased bioenergetic efficiency. To test this hypothesis, we measured the 
bioenergetic function of mitochondria isolated from wildtype, ABCB6 deficient and 
ABCB6 overexpressing livers by determining the oxygen consumption rate (OCR) using 
seahorse XF24 extracellular flux analyzer (Figure 4.3). Isolated mitochondria were 
loaded into different wells of the same seahorse plate and assayed with succinate as 
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fuel. Prior to the assay, we confirmed that equal amounts of functional mitochondria and 
mitochondrial content were present in all mitochondrial preparations by directly staining 
and imaging the wells of the XF24 flux analyzer plate with Mitotracker (Figure 4.3A), 
and by immunoblot analysis of mitochondrial preparations for equal protein content 
(Figure 4.3B). Extracellular flux analyzer studies revealed a significant decrease in 
basal respiration, ATP-synthesizing respiration (state III) and maximal respiratory 
capacity induced by uncoupling with FCCP (maximal) in Abcb6LKO mitochondria 
compared to Abcb6WT mitochondria (Figure 4.3C). In contrast these same parameters 
were significantly increased in Abcb6LOE mitochondria compared to Abcb6WT 
mitochondria (Figure 4.3D). 
     The oxidative phosphorylation system, consisting of the four multimeric enzyme 
complexes (CI–CIV) of the respiratory chain, and the ATP synthase complex (CV), 
drives the synthesis of ATP in most cells and defines the bioenergetic efficiency of the 
mitochondria. We wondered whether altered expression of oxidative phosphorylation 
complexes contributed to the differential bioenergetic capacity of the hepatic 
mitochondria in ABCB6 deficient and ABCB6 overexpressing mice. To test this, we 
performed a denaturing gel electrophoresis of mitochondrial proteins isolated from 
Abcb6LKO, Abcb6LOE, and Abcb6WT mice liver. We first confirmed that equal 
amounts of protein were loaded by staining western blot membranes with the non-
specific protein dye Ponceau S (Figure 4.3E & Figure 4.3F). To control for mitochondrial 
protein loading, we normalized bands to the mitochondrial protein Porin, which did not 
vary significantly between samples. Surprisingly, western blot analysis revealed no 
significant difference in the protein levels of any of the complexes in either the 
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Abcb6LKO or Abcb6LOE mice compared to Abcb6WT controls (Figure 4.3G and 4.3H). 
Quantification of the protein bands in the immunoblots allowed confirmation of the lack 
of significant differences in the expression of respiratory complexes between the Abcb6 
genotypes (Figure 4.3I and Figure 4.3J). 
     With the advent of native electrophoretic gel systems that could separate large 
membrane complexes, respiratory super complexes were shown in a wide variety of 
eukaryotes, including yeast, plants, and animals (Genova, et al., 2014; Schagger et al., 
2000). These super complexes have been hypothesized to be important in stabilizing 
the levels of the individual respiratory complexes themselves, and increasing the 
efficiency of electron transport, thus enhancing the overall respiratory complex activity 
and mitochondrial function (Greggio et al., 2017; Lapuente-Brun et al., 2013). Given the 
lack of difference in respiratory complex protein levels in Abcb6LKO and Abcb6LOE 
mitochondria, we speculated if the differences in respiratory capacity could be due to 
changes in the assembly of respiratory super complexes. To test this, we analyzed 
super complex assembly in Abcb6LKO, Abcb6LOE and Abcb6WT mitochondria using 
native gel electrophoresis (blue native PAGE; BNPAGE). As with the denaturing gel 
electrophoresis, in BNPAGE we first confirmed that equal amounts of protein were 
loaded by normalizing bands to the mitochondrial protein VDAC, which did not vary 
significantly between samples. We first labeled in detail the specific SCs in Abcb6WT 
mice using the most recent description and characterization of SC structure in 
mammalian tissues (Greggio, et al., 2017). In line with previous reports, CI was mostly 
found in super-assembled species. CII existed predominantly, but not exclusively, as a 
single band. CIII and CIV existed both as free and super-assembled species (Figure 
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4.3K). Interestingly, blue native PAGE revealed an overall decrease in the assembly of 
SCs (specifically SCs I+III+IV) in Abcb6LKO mice, while an overall increase in SC 
assembly was observed in Abcb6LOE mice, compared to control Abcb6WT mice 
(Figure 4.3L). Quantification of BNPAGE confirmed significant differences in SCs in 
Abcb6LOE and Abcb6LKO mice (Figure 4.3M). To establish this observation further we 
analyzed the distribution of CI and CIII SCs, the two most prominent SCs in mammals. 
We observed that the fraction of CI and CIII allocated to SCs were lower in Abcb6LKO 
mice and higher in Abcb6LOE mice compared to the Abcb6WT controls (Figures 4.3N 
and 4.3O). Quantification of BNPAGE CI and CIII SCs allowed us to confirm a 
significant change in the assembly of SCs I and III between the genotypes (Figures 
4.3P and 4.3Q). 
     Taken together our results suggest that ABCB6 expression dependent change in 
mitochondrial function is driven by reorganization of the OXPHOS super complexes 

































































































































Figure 4.3 ABCB6 expression affects hepatic bioenergetic capacity 
 (A) Representative fluorescence microscopy image of Seahorse respirometry plate wells 






analysis of VDAC and Tom20 in mitochondria that were in the Seahorse respirometry plates. (C 
- D) Quantification of OCR at different mitochondrial respiratory states in a representative 
experiment using mitochondria isolated from (C) Abcb6WT and Abcb6LKO mice and (D) 
Abcb6WT and Abcb6LOE mice, driven with succinate. ADP, oligomycin, FCCP, and antimycin 
were sequentially injected to assess mitochondrial respiratory states. 4-6 replicates per group. 
(E and F) Western blot analysis of (E) Abcb6WT and Abcb6LKO mitochondria and (F) 
Abcb6WT and Abcb6LOE mitochondria stained with the dye Ponceau S for total protein loading. 
(G-H) Representative western blot analysis of OXPHOS complex subunits I-V (CI-CV) in 
mitochondria isolated from (G) Abcb6WT and Abcb6LKO mice and (H) Abcb6WT and 
Abcb6LOE mice. Porin is used as a loading control. (I-J) Quantification of OXPHOS complex 
subunits (average of n=5 independent isolations) normalized to Porin loading control in 
mitochondria isolated from (I) Abcb6WT and Abcb6LKO mice and (J) Abcb6WT and Abcb6LOE 
mice. (K) Representative BN-PAGE analysis of mitochondrial extracts from Abcb6WT mice. 
Specific antibodies against individual ETC complexes were used separately. The high molecular 
weight bands (HMW), were mainly composed of SC In+IIIn. The strong band below the HMW, 
primarily composed of I, III, and IV, were defined as SC I+III+IV. (L) Representative BN-PAGE 
of mitochondrial extracts from Abcb6WT, Abcb6LKO and Abcb6LOE mice probed with 
OXPHOS antibody cocktail. (M) Quantification of the total amount of SCs (average of n=5 
independent isolations) in Abcb6WT, Abcb6LKO and Abcb6LOE mice. Abcb6WT SC content 
was used to normalize Abcb6LKO and Abcb6LOE SC expression. Values represent mean ± 
SD. ‘a’ significantly different from Abcb6WT; p<0.001. ‘b’ significantly different from Abcb6LKO; 
p< 0.01  
(N and O) BNPAGE analysis of (N) complex I and (O) complex III super-assemblies in 
mitochondria isolated from Abcb6WT, Abcb6LKO and Abcb6LOE mice. (P and Q) Quantification 
of the total amount of SCs I and III in Abcb6WT, Abcb6LKO and Abcb6LOE mice; Average of 
n=5 independent isolations. Abcb6WT SC content was used to normalize Abcb6LKO and 
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Abcb6LOE SC expression. ‘a’ significantly different between Abcb6WT vs Abcb6LKO; p<0.001. 
‘b’ significantly different between Abcb6WT vs Abcb6LOE; p< 0.01. Histograms represent mean 
± SD 
 
Hepatic ABCB6 expression oscillates in sync with fasting and feeding signals. 
     Multiple lines of evidence demonstrate that in the liver, mitochondrial dynamics of 
fusion and fission is closely linked to support the changing bioenergetic demand (Jacobi 
et al., 2015; Lionetti et al., 2014; Smith, et al., 2018b). Based on the strong association 
between hepatic mitochondrial form and function, and the Abcb6 genotype, we wondered 
whether under physiological conditions ABCB6 expression was regulated to link 
bioenergetic demand to mitochondrial dynamics. To test this, we measured ABCB6 
expression in two physiological relevant mouse models, postprandial (Figure 4.4A) and 
circadian rhythm (Figure 4.4B), where mitochondria undergo cyclical changes in their 
shape, size and distribution to adapt their bioenergetic and biosynthetic output to the ever-
changing anabolic/catabolic state of the liver (Jacobi, et al., 2015; Sood et al., 2014). We 
used the activation of nutrient-sensing mechanistic/mammalian target of rapamycin 
complex 1 (mTORC1) to confirm that mice were responsive to the fasting and feeding 
protocol used in our studies (Albert et al., 2015; Laplante et al., 2009, 2012) (Figure 4.4E). 
Similarly, we used circadian oscillation of Period Circadian Regulator 2 (Per2) to confirm 
circadian rhythm in our mouse models (Schmutz et al., 2012) (Figure 4.4G and 4.4H). 
ABCB6 expression was evaluated in these models at both the transcription and 
translational levels. We found that in the postprandial mouse model (Figure 4.4A) ABCB6 
expression was induced in response to fasting, while feeding decreased ABCB6 
expression (Figure4.4E). More interestingly we found that fasting dependent increase in 
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ABCB6 expression was regulated at the transcriptional level (Figure 4.4D) with the 
highest expression seen after an overnight fast ~12 h. In contrast to fasting, feeding 
mediated decrease in ABCB6 expression appeared to be regulated at the post-
transcriptional level, as we did not observe any change in the ABCB6 transcript following 
feeding (Figure 4.4D). Quantification of ABCB6 protein bands in immunoblots confirmed 
significant decrease in ABCB6 expression (Figure 4.4F). 
To confirm the feeding dependent decrease in ABCB6 expression and to explore 
the dynamics of this process we developed an ex vivo model of postprandial using primary 
hepatocytes isolated from Abcb6WT mice. In this ex vivo model Abcb6WT mouse primary 
hepatocytes were cultured in either low nutrient (5 mM glucose) or high nutrient (25 mM 
glucose) media to replicate the in vivo fasting and feeding conditions. Further, to define 
the dynamics of feeding on ABCB6 expression we analyzed the time dependent decrease 
in ABCB6 protein by western blot. Consistent with the in vivo results, ex vivo ABCB6 
expression was eliminated following 5 h of culturing in high nutrient media (Figure 4.4I). 
More importantly we observed a significant decrease (> 75%) in ABCB6 protein as early 
as 1 h of culturing in high nutrient media (Figure 4I). Quantification of the protein bands 
in immunoblots confirmed significant decrease in ABCB6 expression in response to 
nutrient load in primary hepatocytes (Figure 4.4J).   
In the circadian rhythm model, we found a rather sluggish synchronization of the 
Abcb6 transcript with the circadian clock (Figure 4.4C). However, in contrast to the Abcb6 
transcript, ABCB6 protein showed robust synchronization with the diurnal rhythm (Figure 
4.4G). Quantification of the immunoblot protein bands allowed us to plot the circadian 
109 
 
profile of the ABCB6 protein which was phase reversed to the circadian oscillation of Per2 
protein (Figure 4.4H).   
Taken together these results suggest that hepatic ABCB6 expression is in sync with 
physiological and environmental stimuli where hepatic bioenergetic and biosynthetic 



















































































Figure 4.4 Hepatic ABCB6 expression in response to diurnal bioenergetic demand (A) 
Schematic representation of the postprandial model used in this study. (B) Schematic 
representation of the circadian model used in this study. (C) Double-plotted average (±SEM, 
n=4) mRNA levels of Abcb6 in liver at different times of the day. Transcript levels were 
measured by qRT-PCR and normalized to Gapdh mRNA levels. Broken line separates double 
plotted data. 
 (D) Abcb6 mRNA transcript in Abcb6WT mouse liver in response to postprandial. (E) ABCB6 
protein expression in Abcb6WT mouse liver in response to postprandial. pS6K1 and p4EBP1 
were used to confirm feeding and fasting responses and Porin was used as loading control. (F) 
Quantification of ABCB6 protein in Immunoblots normalized to Porin loading control (average of 
n= 3 independent experiments with 4-5 mice per group per experiment). (G) Circadian 





hours for 24 hours (n=3-4 mice/time point). Per2 expression was used to confirm circadian 
rhythm and Porin was used as loading control. (H) Quantification of ABCB6 and Per2 
Immunoblots normalized to Porin loading control (average of n=3 independent experiments with 
3-4 mice per group per experiment). The white and black bar represents light cycle and dark 
cycle, respectively. Zeitgeber time 0; lights on; 12; lights off. The dotted line separates one 24 h 
(day and night) cycle. (I) Representative Immunoblot analysis of ABCB6 protein expression in 
primary hepatocytes isolated from Abcb6WT mice livers cultured in the presence of either low-
nutrient (5 mM glucose) or high nutrient (25 mM glucose) for the indicated periods. Actin is used 
as a loading control. (J) Quantification of immunoblots normalized to actin (average of n=3 
independent primary hepatocyte isolations). Values represent mean ± SD. ‘a’ significantly 
different from low nutrient; p < 0.001. ‘b’ significantly different from high nutrient at 1 h; p < 
0.001. ‘c’ significantly different from high nutrient at 3 h; p<0.001. High 1, High 2, High 3, High 4, 
and High 5 represent hepatocytes treated with high nutrient media for 1 h, 2 h, 3 h, 4 h and 5 h 
respectively. 
 
Dynamic changes in hepatic ABCB6 expression is required to accommodate 
mitochondrial form and function in response to hepatic bioenergetic demand. 
     Based on the synchronization of hepatic ABCB6 expression with bioenergetic demand 
and mitochondrial form and function, we hypothesized that dynamic changes in ABCB6 
expression may be essential to accommodate hepatic bioenergetic demand to the 
mitochondrial life cycle of fusion and fission. To test this hypothesis, we first determined 
the dynamic changes in mitochondrial form and function in Abcb6WT mice in response 
to fasting and feeding using the postprandial mouse model described in Figure 4.4A. In 
Abcb6WT mice, a shift from ad libitum feeding to fasting reprogramed hepatic 
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mitochondria into a more fused or elongated morphology (Figure 4.5A) with a significant 
decrease in mitochondrial number (Figure 4.5B) without any significant change in total 
mitochondrial area (data not shown). Consistent with the more fused morphology, Abcb6 
WT mitochondria displayed increased basal respiration, ATP-synthesizing respiration 
(state III) and maximal respiratory capacity (FCCP uncoupled) (Figure 4.5C). In contrast, 
a shift from fasting to refeeding resulted in shortened or fragmented mitochondria with a 
significant decrease in basal respiration, ATP-synthesizing respiration (state III) and 
maximal respiratory capacity (Figure 4.5A – 5C).  
Using the mitochondrial form and functional changes observed in the Abcb6WT 
mice liver as the benchmark we next tested how these parameters were altered in 
Abcb6LKO and Abcb6LOE mice livers. We found that in Abcb6LKO mice, hepatic 
mitochondria were unable to undergo fusion (Figure 4.5D), decrease mitochondrial 
number (Figure 4.5E) or increase mitochondrial bioenergetic profile in response to energy 
demand (fasting) (Figure4.5F). However, in the fed conditions Abcb6LKO mice responses 
were similar to the Abcb6WT mice (Figure 4.5D-5F). In contrast to Abcb6LKO mice, 
Abcb6LOE mice were unable to undergo fission (Figure 4.5G), increase mitochondrial 
number (Figure 4.5H) or decrease bioenergetic efficiency in response to nutrient 
availability (feeding) (Figure 4.5I). However, in the fasted condition Abcb6LOE mice 
responses were similar to the Abcb6WT mice (Figure 4.5G – 5I). Together these results 
confirm our hypothesis and suggest that disturbances in hepatic ABCB6 expression 
results in an inability of these respective mitochondria to adapt their mitochondrial form 
and function to the changing energetic demands. By extension these results imply that 
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ABCB6 expression is an essential component in linking bioenergetic demand to 






























Figure 4.5 (A-I) ABCB6 expression affects postprandial remodeling of mitochondrial form 
and function and metabolic homeostasis (A, D, G) Representative EM images showing 
mitochondrial ultrastructural morphology in response to fasting and refeeding in (A) Abcb6WT, 
(D) Abcb6LKO and (G) Abcb6LOE mitochondria. (B, E, H) Mitochondrial number changes in 
response to fasting and feeding in (B) Abcb6WT, (E) Abcb6LKO and (H) Abcb6LOE mice. 
Mitochondrial number was calculated in 12 images (2 images per mice per genotype per 
condition) each of 980 µm2 representing 6 mice per genotype per condition. Values represent 
mean ± SD. (C, F, I) Quantification of OCR at different mitochondrial respiratory states in a 
representative experiment using mitochondria isolated from (C) Abcb6WT, (F) Abcb6LKO and (I) 
Abcb6LOE in response to fasting and feeding. 
Dynamic changes in hepatic ABCB6 expression is required to accommodate 
hepatic metabolic flexibility in response to hepatic bioenergetic demand. 
     A key aspect of synchronizing mitochondrial form and function in response to 
bioenergetic demand is to drive cellular adaptations that facilitate efficient use of available 
nutrients (glucose, lipids, and amino acids) (Gao, et al., 2014; Pintus, et al., 2012; Singer, 
2013). Such adaptations promote hepatic metabolic homeostasis (metabolic flexibility) 
(Cheng, et al., 2013; Smith, et al., 2018b). Conversely, loss of this synchronization impairs 
metabolic homeostasis (Chowdhury et al., 2013; Corpeleijn, et al., 2009; Lopez-Lluch, 
2017). We speculated whether an inability to accommodate mitochondrial form and 
function to nutrient status in Abcb6LKO and Abcb6LOE mice results in impaired metabolic 
flexibility. To test this hypothesis, we first defined the parameters of energy usage, 
including fed and fasted hepatic ketone body production, glycogen depletion and 
triacylglycerol accumulation in Abcb6WT mice. Consistent with previous observations 
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(Arias et al., 1997; Geisler et al., 2016; Seitz et al., 1977), fasting Abcb6WT animals 
showed increased hepatic ketone body production, glycogen depletion and triacylglycerol 
accumulation (Figures 4.5J – 5L and Figures 4.5P-5Q), while feeding Abcb6WT animals 
showed repletion of glycogen stores, and decreased beta-oxidation (Figures 4.5M – 5O).  
     Using the metabolic adaptations observed in Abcb6WT mice as benchmark we then 
tested how these parameters were altered in Abcb6LKO and Abcb6LOE mice. We found 
that Abcb6LKO mice were blunted in their ability to mobilize hepatic ketone body 
production (Figure 4.5J) and glycogen depletion (Figure 4.5K and Figure 4.5P) in 
response to fasting. In addition, fasting hepatic triglyceride content was significantly 
increased in the Abcb6LKO mice compared to Abcb6WT mice (Figures 4.5L and 4.5Q). 
However, in the fed state Abcb6LKO mice display features that are consistent with the 
Abcb6WT mice with repletion of hepatic glycogen stores and inhibition of beta-oxidation, 
although these parameters were much more significantly affected in Abcb6LKO mice 
compared to Abcb6WT mice (Figures.4.5M – 5O).  
     In contrast to Abcb6LKO mice, in Abcb6LOE mice fasting induced hepatic ketone body 
production and liver glycogen content were higher than that observed in the Abcb6WT 
mice (Figures 4.5J and4.5K respectively). However, these values did not reach statistical 
significance.  In contrast to serum ketones and liver glycogen content, the liver triglyceride 
content of fasting Abcb6LOE mice was significantly lower compared to Abcb6WT mice 
(Figure 4.5L). Interestingly in the fed state no significant differences were observed 
between Abcb6LOE and Abcb6WT mice with respect to liver glycogen content or liver 
triglyceride levels (Figures 4.5M – 5O). Together these observations suggest that 
Abcb6LKO mice appear to be in a fed state with an inability to adapt to the metabolic 
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demands of the fasted state, while Abcb6LOE mice appear to show metabolic features, 
some of which, are consistent with the fasted state. 













Figure 4.5 (J-Q) continued 
 
 
Figure 4.5 (J-Q) ABCB6 expression affects postprandial remodeling of mitochondrial 
form and function and metabolic homeostasis (J and M) Serum ketones, (K and N) Liver 
glycogen, and (L and O) Liver TG in fasted (J-L) and fed (M-O) Abcb6WT, Abcb6LKO 
and Abcb6LOE mice. Values represent mean ± SD. N= 3 independent experiments with 
5 mice per group per experiment per condition. (P) Representative tissue sections 
showing fasting liver glycogen content assessed using periodic acid-Schiff stain. (Q) 
Representative tissue sections showing fasting liver lipid content assessed using Oil-O 
Red stain. ‘a’ significantly different from Adlib values in panels ‘C, F, and I’ and 





fasted values in panels ‘C, F, and I’ and significantly different from LKO in panels ‘J – O’; 
p<0.001. NS; values are statistically not significant. 
Metabolic inflexibility in mice with altered ABCB6 expression leads to early signs 
of metabolic disease. 
     A lack of metabolic flexibility is a significant contributing factor in the development of 
metabolic disease which includes obesity, insulin resistance and other comorbidities of 
metabolic syndrome (Corpeleijn, et al., 2009; Galgani, et al., 2008; Sieber et al., 2017; 
Smith, et al., 2018b). Given the strong association between ABCB6 expression and 
metabolic inflexibility, we wondered whether chronic hepatic ABCB6 deficiency or hepatic 
ABCB6 sufficiency contributes to metabolic comorbidities associated with metabolic 
inflexibility. To test this, we initiated a study to define how ABCB6 expression affected 
food consumption, body composition and body weight change as well as parameters of 
metabolic disease. We placed 4-week-old (post weaning) Abcb6LKO, Abcb6LOE, and 
Abcb6WT mice on chow diet with ad libitum feeding, and followed the changes in weight 
gain, and food consumption (Figures 4.6A-6C). We observed that during the first 5 weeks 
of this study (week 6 to week 10) both Abcb6LKO and Abcb6LOE mice consumed 
significantly less food than the Abcb6WT mice (Figure 4.6B). However, this pattern in 
food consumption changed dramatically in the next three weeks (week 11 to week 13) 
with Abcb6LOE mice consuming significantly more food than Abcb6WT mice, and 
Abcb6LKO mice consuming significantly less food than the Abcb6WT mice (Figure 4.6B).   
Interestingly, we found that the Abcb6LKO mice consistently gained weight compared to 
Abcb6WT mice when normalized to food consumption (Figure 4.6C). In contrast the 
Abcb6LOE mice showed no significant difference in normalized body weight (normalized 
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to food consumption) during the first 5 weeks (Figure 4.6C) of the study. However, this 
changed dramatically during the next three weeks (week 11 to week 13) with Abcb6LOE 
mice showing a significant decrease in normalized body weight (normalized to food 
consumption) compared to Abcb6WT mice (Figure 4.6C).    
     To identify parameters of metabolic disease mice in each group were subjected to 
glucose and insulin tolerant tests at the end of 13 weeks. We observed that the Abcb6LKO 
mice were glucose intolerant in the glucose tolerance test (Figure 4.6H) with the 
calculated area under the curve (AUC) being statistically significant (Figure 4.6I). We also 
observed that the Abcb6LKO mice were insulin resistant at later time points (90 and 120 
min) in the insulin tolerance test (Figure 4.6J), however the calculated area under the 
curve (AUC) for insulin tolerance was not statistically significant (Figure 4.6K) compared 
to Abcb6WT mice. In contrast to Abcb6LKO mice, Abcb6LOE mice showed improved 
glucose tolerance and insulin sensitivity compared to Abcb6WT mice, although these 
differences were not statistically significant for the most part (Figures 4.6L – 6O).  
To identify additional parameters of metabolic disease the chow diet study was 
terminated at the end of 13 weeks and mice in each group were sacrificed. Serum and 
tissues were collected from the sacrificed mice and parameters of metabolic disease 
including fed and fasted serum triglycerides (TG) and serum free fatty acids (FFA) were 
assessed. We found that in both the fed and fasted states, serum TG (Figures 4.6D and 
4.6F), and serum FFA (Figures 4.6E and Figure 4.6G) were significantly higher in 
Abcb6LKO mice compared to Abcb6WT mice. In contrast in Abcb6LOE mice we 
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observed decreased serum FFA under fed conditions (Figure 4.6G) while fasting serum 
FFA and fasting serum TG were high compared to Abcb6WT mice (Figures 4.6D and 6E).  
     The unique pattern of serum parameters combined with the distinctive body weight 
changes seen in Abcb6LKO and Abcb6LOE mice prompted us to evaluate the size and 
weight parameters of liver and adipose tissue, two key organs that are thought to 
contribute to body weight changes and the observed serum metabolite changes. We 
found that in Abcb6LKO mice both the liver and the white adipose tissue were heavier 
(normalized to body weight) compared to the liver and white adipose tissue of Abcb6WT 
mice (Figures 4.6P and 4.6Q). In contrast in Abcb6LOE mice the liver and the white 
adipose tissue (normalized to body weight) were lighter compared to the liver and white 
adipose tissue of Abcb6WT mice (Figures 4.6P and 4.6Q). More importantly the organ to 
body weight ratio observed in Abcb6LKO mice were significantly higher than the organ to 
body weight ratio seen in Abcb6LOE mice (Figures 46P and 46Q).  
     Taken together these results suggest that in mice chronic hepatic ABCB6 deficiency 















































































Figure 4.6 Early signs of metabolic disease in male mice on chow diet as a result of chronic 








(A) Body weight, (B) food consumption and (C) body weight change normalized to food consumed 
in Abcb6WT, Abcb6LKO and Abcb6LOE mice. (D-G) serum biochemical parameters of 
Abcb6WT, Abcb6LKO and Abcb6LOE mice in (D, E) fasted and (F, G) fed conditions. (H, I) 
glucose and (J, K) insulin response in Abcb6WT and Abcb6LKO mice. (L, M) glucose and (N, O) 
insulin response in Abcb6WT and Abcb6LOE mice. ‘a’ significantly different from WT; p<0.001. 
‘b’ significantly different from LKO; p<0.001 in serum biochemical parameters. ‘c’ significantly 
different from WT; p<0.001. ‘d’ significantly different from LOE; p<0.001 in body weight and food 
consumption. (P, Q) Organ to body weight ratios for Abcb6LKO and Abcb6LOE mice (p values 
listed). Results representative of 4 independent experiments with 5 – 6 mice per group per 
experiment. Values represent mean ± SD. 
ABCB6 expression alters localization of mitochondrial fission and fusion proteins 
     To elucidate the mechanism by which ABCB6 expression affects mitochondrial 
morphology, we carried out cell fractionation experiments to determine the effect of 
ABCB6 on the expression and localization of the core proteins that regulate mitochondrial 
dynamics. In principal mitochondrial dynamics is controlled by the amount, localization 
and activity of the dynamin related proteins Mfn1, Mfn2, Opa1 and Drp1 (Bereiter-Hahn 
et al., 1994; Ferree et al., 2012; Hermann et al., 1998; Lee et al., 2016). In the following 
studies we first measured the expression of Mfn1, Mfn2, Opa1, and Drp1 in livers of 
Abcb6LKO and Abcb6LOE mice. We found no significant differences in the expression of 
any of the core mitochondrial fusion or fission proteins in either Abcb6LKO or Abcb6LOE 
mice (Figures 4.7A and 4.7E). We next tested whether mitochondrial localization of the 
fusion and fission proteins were different between the three mouse genotypes. We 
observed decreased mitochondrial localization of MFN2 and OPA1 and increased 
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mitochondrial localization of DRP1 in Abcb6LKO mice (Figures 4.7C and 4.7G). In 
contrast, in Abcb6LOE mice we found increased mitochondrial localization of Mfn2 and 
Opa1 and decreased mitochondrial localization of DRP1 compared to wildtype mice 
(Figures 4.7C and 4.7G). Quantification of the protein bands normalized to loading 
controls confirmed the immunoblot results (Figures 4. 7B, 4.7D, 4.7F & 4.7H). Collectively 
these results suggest that altered ABCB6 expression affects mitochondrial localization of 












Figure 4.7 continued 
 
 
Figure 4.7 Effect of ABCB6 on the expression and mitochondrial localization of Mfn2, 
Opa1 and Drp1  
(A-H) Representative western blot analysis of (A & C) fusion protein and (E & G) fission protein 
distribution between (A & E) whole liver lysate and (C & G) mitochondrial fractions. Porin and 
VDAC were used as loading controls for the mitochondrial fractions and actin was used as 
loading control for the total lysate fractions. (B, D, F, H) Quantification of immunoblots (n=5 
independent experiments with 4-5 mice per group per experiment) normalized to Porin, VDAC 
and actin. Values represent mean ± SD. ‘a’ significantly different from WT; p<0.001. ‘b’ 
significantly different from LKO; p<0.001. NS; statistically non-significant. 
4.5 Discussion 
     Mitochondria have a unique ability to change their morphology through fusion and 





an important aspect of mitochondrial respiratory status which entails changes in energy 
and redox alterations, thereby integrating sensing and signaling processes that promote 
hepatic metabolic homeostasis. A major challenge has been to understand the molecular 
mechanisms that couple intracellular and environmental stimuli to mitochondrial 
dynamics. In this study we identify ABCB6, a mitochondrial outer membrane ABC 
transporter protein, as a physiologically controlled regulator of mitochondrial dynamics 
and hepatic energy homeostasis. To our knowledge, this is the first report of a 
mitochondrial ATP binding cassette transporter protein capable of modulating metabolic 
flexibility by simultaneous regulation of mitochondrial dynamics and mitochondrial 
function in the liver. Our studies suggest that hepatic ABCB6 expression is essential to 
promote whole-body metabolic homeostasis and dysregulation in its expression 
contributes to the development of metabolic disease.   
ABCB6 mediated reprograming of mitochondrial function results from altered 
supra complex assembly of respiratory complexes   
     We found that ABCB6 mediated change in mitochondrial form reprograms 
mitochondrial bioenergetic efficiency. Bioenergetic efficiency during oxidative 
phosphorylation is carried out by the electron transport chain (ETC), a composite multi-
protein system organized in four respiratory chain complexes (CI-CIV). The structural and 
functional organization of the ETC defines the efficiency of energy harvest by the 
mitochondria(Lenaz et al., 2009). Recent studies suggest that the structural and 
functional organization of the ETC plastically changes from freely moving to super-
assembled structures, called super complexes (Cogliati et al., 2013). Indeed, change in 
mitochondrial morphology is thought to reorganize cristae architecture that promotes 
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higher order organization of the respiratory complexes into super assemblies, often 
without any significant change in the expression of the individual complexes (Cogliati, et 
al., 2013; Lenaz, et al., 2009; Schagger, et al., 2000). Such SCs are believed to reduce 
the diffusion distance required for the transfer of electrons from one complex to the other, 
thereby increasing the transport efficiency and overall mitochondrial function while limiting 
the production of reactive oxygen species (ROS) (Lapuente-Brun, et al., 2013; 
Maranzana et al., 2013). In mice with differences in ABCB6 expression SCs appear to 
dynamically adapt to changes in mitochondrial morphology and be stabilized by cristae 
shape. This ABCB6 mediated adaptation of mitochondrial morphology and the ensuing 
super-assembly of respiratory complexes likely allows hepatocyte mitochondria to 
reprogram mitochondrial function. Consistent with the observation that such SC mediated 
changes in mitochondrial function do not translate into damaging amounts of ROS 
(Maranzana, et al., 2013), mitochondrial functional changes precipitated by differential 
ABCB6 expression does not lead to any significant change in ROS production (data not 
shown). However, whether a shift from dynamic change in ABCB6 expression to chronic 
gain or loss of ABCB6 expression leads to pathologically significant ROS levels requires 
further investigation. 
ABCB6 deficiency or overexpression leads to compromised nutrient sensitivity  
     Normal energy metabolism is characterized by periodic shifts in glucose and fat 
oxidation as the mitochondrial machinery responsible for carbon combustion switches 
freely between alternative fuels according to physiological and nutritional circumstances 
(Gao, et al., 2014; Liesa, et al., 2013). This capacity of the mitochondria to switch between 
fuels is coupled to cellular and/or tissue changes, that promotes fasting and feeding 
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dependent glucose disposal, and lipid storage. An inability to accommodate such switch 
between fuel sources results in aberrant energy metabolism in the liver promoting the 
development of metabolic disease including obesity and insulin resistance (Bournat et al., 
2010; Galgani, et al., 2008; Gomes et al., 2011b; Smith, et al., 2018b).  
     In mice with hepatic ABCB6 deficiency or hepatic ABCB6 overexpression 
mitochondrial capacity to switch between fuels is compromised. Abcb6 deficient mice, 
because of their blunted ability to switch between carbon sources (blunted fat oxidation 
and glycogen depletion in the fasted state), appear to be in a state of over-nutrition and 
unabated substrate competition leading to a phenotype associated with metabolic 
comorbidities of glucose intolerance, and insulin resistance. In contrast ABCB6 
overexpressing mice appear to be glucose tolerant and insulin sensitive. Interestingly, 
ABCB6 deficient mice respond to this state of unabated substrate competition by 
decreasing their food intake. Although the cause of anorexia in these animals should be 
further investigated, the observed feeding adaptation may be a compensatory mechanism 
to slow down excessive weight gain because of low energy efficiency. This is consistent 
with the observation that metabolic signals relating to energy surplus usually trigger 
compensatory changes, including decreased food intake and increased physical activity 
to maintain energy balance (Lenard and Berthoud, 2008). In this context it will be 
informative to assess if Abcb6LKO mice are physically more active either in the form of 
spontaneous physical activity or voluntary physical activity (commonly thought of as 
“exercise”).  
     In contrast to Abcb6LKO mice, Abcb6LOE mice respond to a state of under-nutrition 
with increased food consumption. Although, the underlying molecular mechanisms that 
134 
 
allow Abcb6LOE mice to increase food consumption needs to be elucidated, the observed 
response is consistent with activation of mechanisms that facilitate coping with an energy 
deficit. Under normal circumstances a decrease in fuel availability will be signaled to the 
brain by elevated ghrelin levels and low levels of all other gut hormones and a dip in leptin 
levels (Lenard and Berthoud, 2008). In this context it would be informative to evaluate if 
signaling mechanisms, regulated by hormones such as leptin and ghrelin, are altered in 
these mice to promote fasting responses in brain activity.  
     Most interestingly, in both Abcb6LKO and Abcb6LOE mice, despite the adaption in the 
feeding habits, chronic metabolic pressures appear to compromise nutrient sensitivity 
leading to increased body weight gain in ABCB6 deficient mice and low body weight in 
ABCB6 overexpressing mice. We hypothesize that the increased liver and white adipose 
tissue weight in Abcb6LKO mice results from increased lipogenesis and ensuing lipid 
accumulation in the liver and increased mobilization of fat for storage in adipocytes along 
with decreased lipolysis. Such a hypothesis would be consistent with the observation that 
the Abcb6LKO mice appear to be in a constant fed state and would also help explain the 
increased serum FFA and TG in Abcb6LKO mice irrespective of the nutrient status (fed 
or fasted).  
     In contrast to Abcb6LKO mice, we hypothesize that in Abcb6LOE mice the decreased 
liver and white adipose tissue weight results from decreased lipogenesis in liver and 
increased lipolysis in white adipose tissue resulting in increased mobilization of fat from 
the adipocytes as a potential source of fuel. Consistent with such a hypothesis the 
Abcb6LOE mice show increased serum FFA which would be expected with enhanced 
lipolysis under fasting conditions. 
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     However, it is evident from the discussion presented in the above paragraphs, that a 
detailed analysis of the signaling pathways altered in Abcb6LKO and Abcb6LOE mice, 
not only in the liver but also in white and brown adipose tissue and the muscle, is required 
for a detailed understanding of the complex metabolic phenotype observed in these 
genetically modified mice.  
 
ABCB6 expression is linked to nutrient status 
     Our studies demonstrate that ABCB6 expression is in sync with hepatic bioenergetic 
demands, and that ABCB6 is a required component of the metabolic and cell signaling 
events that enable crosstalk and cooperation between nutritional status and energy 
homeostasis. Fasting results in increased ABCB6 expression which appears to be 
regulated at the level of transcription, while feeding leads to loss of ABCB6 expression 
mediated by post-transcriptional mechanisms. However, at this stage, it is not clear what 
mechanisms link nutritional changes to ABCB6 expression. Three major nutritional 
sensors, mammalian target of rapamycin (mTOR), AMP-activated kinase (AMPK) and 
Sirtuins are involved in the control of mitochondrial physiology (Albert, et al., 2015; Bullon 
et al., 2016; He et al., 2017; Laplante, et al., 2012; Li, 2013; Ross et al., 2016; Sengupta 
et al., 2010). These nutritional sensors control mitochondrial biogenesis, mitochondrial 
dynamics and mitochondrial turnover through mitophagy/autophagy. Future studies will 
explore if ABCB6 is regulated by these pathways, and if so how these pathways are 





ABCB6 expression is casually linked to regulation of core protein machinery that 
governs mitochondrial shape. 
     It has been established that the Dynamin-like GTPases form the core machinery that 
govern mitochondrial shape. The mammalian orthologues of mitofusin 1 and mitofusin 2 
(Mfn1 and Mfn2) and Optic Atrophy 1 (OPA1) are required to maintain a reticular 
mitochondrial network in cells, while the Dynamin-related protein 1 (DRP1) is required to 
promote mitochondrial fragmentation.  Indeed, genetic ablation of mitofusin-1 and 
mitofusin-2 as well as the inner mitochondrial membrane (IMM) GTPase optic atrophy 1 
is embryonic lethal (Chen, et al., 2003; Davies, et al., 2007). Similarly, the loss of the core 
fission GTPase Drp1 is also lethal (Ishihara, et al., 2009). However, unlike the phenotypes 
observed with the complete loss of these Dynamin-like GTPases, adaptive mitochondrial 
response to physiological and environmental stimuli appears to require a tighter 
regulation in their expression and activity. Indeed, the recent characterization of several 
regulatory proteins that control the activity and localization of the core dynamin related 
GTPases indicate that the molecular mechanisms regulating and controlling the 
morphology and function of mitochondria are more elaborate and complex in vertebrates 
(Ali et al., 2018; Chandhok et al., 2018; MacVicar et al., 2016; Santel et al., 2008). Our 
findings demonstrate that ABCB6 might function as a regulatory protein that controls the 
activity of the core dynamin related GTPases by modifying their mitochondrial localization. 
However, the precise mechanism, by which ABCB6 expression regulates differential 

















Chapter 5. Alterations of the Hepatic Metabolome of Fasted and Refed Wild-













Inbred mouse strains are frequently used as a model to study metabolic flexibility. 
Central to these studies are responses during pre-absorptive and post-absorptive 
states. Previous studies demonstrated that liver-specific Abcb6 deficient (Abcb6LKO) 
and liver-specific Abcb6 over expressing (Abcb6LOE) mice, alterations in metabolic 
flexibility responses were manifested in altered food consumption, respiratory exchange 
ratio, and disrupted glucose homeostasis. Further, in these mice, metabolic inflexibility 
was associated with disrupted mitochondrial dynamics. However, the mechanistic 
details of how altered ABCB6 expression leads to disruptions in mitochondrial dynamics 
are unclear. Given that ABCB6 is a membrane transport protein, we hypothesized that 
the phenotype observed in ABCB6 deficiency or over expression might arise from or 
loss of metabolite homeostasis. As a first step in testing this hypothesis, we performed 
an untargeted analysis of hepatic metabolites. To our surprise, preliminary analysis of 
the results demonstrates a role for hepatic ABCB6 in the reorganization of three 
prominent mitochondrial metabolic networks including bile acid, amino acid, and 











Metabolic flexibility is the set of physiological adaptations to energy supply and demand. 
The primary facet of flexibility is the ability to preferentially utilize either carbohydrates or 
lipids as an energy source in response to environmental cues. Societal trends of 
decreased physical activity and increased caloric intake have led to increased average 
body weight and impaired metabolic flexibility that are accompanied by comorbidities 
such Type II diabetes, and metabolic syndrome (Goodpaster et al., 2017). 
     Metabolic flexibility is needed under drastic circumstances such as physical exertion 
and starvation as well as circadian-driven eating patterns. Ensuing the diurnal sleep 
period, the is the fasted state. During this period, stored lipids are utilized to ensure 
adequate blood glucose primarily for the brain and resting metabolic processes. In the 
waking state, food consumption is utilized to maintain blood glucose and excess energy 
is stored as lipids in fat deposits for future use.  
     Maintenance of energy homeostasis through flexibility is accomplished via the 
coordination of interlinked metabolic pathways in multiple tissues. The liver, skeletal 
muscle, adipose tissue, heart, brain, and pancreas orchestrate the utilization, trafficking, 
and storage of energy substrates in response to endocrine signaling. Energy supply and 
demand drives enzymatic activity unique to individual organs that ensures rapid 
switching between carbohydrate and lipid metabolism. These responses are fine-tuned 
by energy sensing transcriptional programs (Smith et al., 2018a). 
     Quantitative analysis of energy pathway metabolites has the potential to pinpoint 
derangements in the function or regulation of metabolic flexibility pathways. Analysis of 
metabolites in individual metabolic tissues under various energy supply conditions 
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would uncover how organ systems contribute to metabolic flexibility. Comparisons of the 
responses from individual metabolic tissues could also elucidate the how organ-organ 
crosstalk regulates overall metabolism. As a first step in understanding how individual 
organs contribute to maintaining energy homeostasis, and how physiological responses 
are integrated during nutrient state transitions, we initiated the analysis (completed by 
Metabolon Inc, Research Triangle Park, NC) of global metabolites in fasted (18 hours) 
and refed (6 hours) mouse liver in wild-type (WT), Abcb6 liver-specific knock out 
(Abcb6LKO), and Abcb6 liver-specific over expressing (Abcb6LOE) 8-week male mice.  
     To our knowledge, this is the first study of its kind and as such, will assist in further 
defining the liver’s role in metabolic flexibility. Also, this knowledge base of hepatic 
responses to nutrient state in wild-type mice can serve as a basis of comparison for 
other pharmacological or genetic treatments. In the case of our ABCB6 model of 
metabolic inflexibility, this study is especially appropriate and will potentially assist in 






Summary of Super Pathway Changes in Fasted and Refed Mouse Liver 
     Data analysis was organized in a hierarchical manner with “Super pathways” being a 
large group of physiologically related sub pathways and with individual biochemicals 
(metabolites) being grouped within the sub pathways. The nomenclature “pathway” 
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does not necessarily indicate biochemical pathways per se, but rather, a convenient 
way to organize related biochemicals. For instance, the “Energy” super pathway 
contains metabolites generated from Krebs cycle and oxidative phosphorylation 
activities. Figures 5.1 A-H show the magnitude of change of the 8 “super pathways” 
Amino Acids, Carbohydrates, Energy, Lipids, Nucleotides, Peptides, Vitamins, and 
Xenobiotics from the fasted to refed state in WT, Abcb6LKO, and Abcb6LOE mice. 
      Values represented are the average sums of all metabolite peak values within the 
super pathway. In WT mice, food intake resulted in an increase in 6 of the 8 super 
pathways (Amino Acids, Carbohydrates, Energy, Peptides, Vitamins, and Xenobiotics). 
The Carbohydrate, Vitamin, and Xenobiotic super pathways reached statistical 
significance (Figures 5.1A-1C and 5.1F-1H). In contrast, the Lipid and Nucleotide super 
pathways in WT mice were decreased in the refed state with the Lipid super pathway 
reaching statistical significance (Figures 5.1D and 5.1E).  
     In Abcb6LKO mice, the same 6 super pathways were increased in the refed state 
with the Amino Acid, Carbohydrate, Vitamin, and Xenobiotic categories reaching 
statistical significance (Figures 5.1A- 1C, and 5.1F-1H). Lipid and Nucleotide super 
pathways were reduced in LKO mice as in the WT group. Again, with only the Lipid 
super pathway decrease reaching significance statistically (Figures 5.1D and 5.1E). In 
Abcb6LOE mice, the Amino Acid, Peptide, and Vitamin super pathways were not 
increased in response to feeding (Figure 5.1A, 5.1F, and Figure 5.1G). Both the Lipid 
and Nucleotide super pathway fasting mediated increase reached significance in 
Abcb6LOE mice (Figures 5.1D and 5.1E). Refed Abcb6LOE mice had significantly lower 
Vitamin super pathway values than both WT and Abcb6LKO mice (Figure 5.1G). 
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     Although the super pathway analysis showed significant differences between the 
experimental condition (fasted or refed), this type of analysis did not demonstrate 



























Figure 5.1. Metabolic super pathway changes in response to fasting and refeeding in WT, 
Abcb6LKO, and Abcb6LOE mouse liver (A)-(H) Total peak values in the Amino Acid, 
Carbohydrate, Energy, Lipid, Nucleotide, Peptide, Vitamin, and Xenobiotic super pathways. 
N=4.  
 
Amino Acid Metabolites in Fasted and Refed Mouse Liver 
     The liver utilizes amino acids for protein synthesis as well as for a glucogenic or 
ketogenic energy source. They are obtained exogenously from meals via portal 
circulation, de novo synthesis, or from protein and peptide degradation. In WT mice, 
total amino acids were slightly but non-significantly increased in response to feeding 
(Figure 5.1A). The main contributing factor to the overall increase in amino acids was 
the significant increase in the glutathione sub pathway (Figure 5.2A). The 
Methionine/Cysteine/SAM/Taurine sub pathway metabolites are necessary for 
glutathione production and intuitively, were also increased in the refed state (Figure 
5.2B). Conversely, the glucogenic amino acid sub pathways Alanine/Aspartate and 
Histidine were increased in the fasted state with the Alanine/Aspartate sub pathway 
reaching statistical significance (Figures 5.2C and 5.2D). The ketogenic amino acid sub 
pathway Lysine was also significantly increased in the fasted state with the other major 
ketogenic sub pathway, Leucine/Isoleucine/Valine also being increased but not reaching 
statistical significance (Figures 5.2E and 5.2F). Within the Glutathione sub pathway, the 
reduced form of glutathione (GSH) metabolite was the main contributor to the increase 
in response to feeding (data not shown). The observed feeding induced increase in 
GSH in this study agrees with published data in rat liver (Yamada et al., 2018). Higher 
glucogenic and ketogenic amino acid levels seen in WT mouse liver in the fasted state 
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may indicate increased import from extrahepatic tissues in the fasted state to support 
increased gluconeogenesis and ketosis.  
     As previously noted, Abcb6LKO refed mice had a significantly higher Amino Acid 
super pathway levels compared to fasted LKO mice (Figure 5.1A). Like the WT group, 
the major contribution to the increase was the Glutathione sub pathway (also due to 
GSH) with the Methionine/SAM/Taurine sub pathway following the same expected 
trend. Strikingly, the increases in the Amino Acid super pathway, Glutathione and 
Methionine/SAM/Taurine sub pathways were not seen in Abcb6LOE mouse liver 
(Figures 5.1A,5.2A, and 5.2B). Rather, these pathways were not significantly changed 
in response to feeding. In fact, Abcb6LOE Amino acid levels were significantly lower 
than Abcb6LKO in the fed state (Figures 1A, 5.2A, and 5.2B). Glucogenic amino acids 
in the Histidine and Alanine/Arginine sub pathways in the Abcb6LKO and Abcb6LOE 
followed the same fasting-induced increase trend as WT mice with feeding response 
reaching statistical significance. However, the fasted Abcb6LKO Alanine/Aspartate sub 
pathway level was significantly lower than both the WT and Abcb6LOE groups (Figure 
5.2C and 5.2D). The ketogenic Leucine/Isoleucine/Valine sub pathway was, as in the 
WT group, increased in response to fasting in Abcb6LKO and Abcb6LOE mice with only 
the Abcb6LOE group reaching significance (Figure 5.2F). The other ketogenic sub 
pathway, Lysine, was also increased in response to fasting in Abcb6LKO and 
Abcb6LOE groups but only in the Abcb6LKO group did the increase reach significance. 
However, in both Abcb6LKO and Abcb6LOE mice, the fasted level of the Lysine sub 
pathway was significantly lower compared to WT mice (Figure 5.2E).  
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     The two main concepts derived from analysis of amino acid sub pathways are, 
glutathione metabolism is increased in response to feeding and glucogenic/ketogenic 
amino acids are increased in the fasted state in mouse liver. In Abcb6LOE mice, the 
feeding-induced glutathione increase is extremely blunted. Also, both Abcb6LKO and 
Abcb6LOE mice had generally less drastic increases in glucogenic/ketogenic amino 












Figure 5.2. Metabolic Amino Acid sub pathway changes in response to fasting and 
refeeding in WT, Abcb6LKO, and Abcb6LOE mouse liver (A)-(F) Total peak values in the 
Glutathione, Methionine/SAM/Taurine, Alanine/Aspartate, Histidine, Lysine, and the 








Carbohydrate Metabolites in Fasted and Refed Mouse Liver 
     A major function of the liver is to maintain blood glucose within a narrow range in 
both fasted and fed conditions. In the fed state, excess carbohydrates are stored as 
glycogen or are converted to fatty acids via de novo lipogenesis. During a fast, hepatic 
glycogen stores are converted to glucose which is subsequently exported to circulation. 
Concomitantly, hepatic gluconeogenesis activity increases to maintain blood sugar as 
glycogen stores are depleted. During the fasted period, the liver foregoes maintenance 
of its own glucose supply to provide for extrahepatic tissues. This phenomenon is 
demonstrated in our study with a greater than 2-fold reduction of hepatic glucose in the 
fasted state in WT mouse liver (Figure 5.3A). In the WT group, the carbohydrate super 
pathway was significantly increased in response to feeding (Figure 5.1B). The Glycogen 
sub pathway was expectedly significantly increased in the refed state (Figure 5.3B). The 
Fructose/ Mannose/Galactose sub pathway also contributed to the overall increase in 
hepatic carbohydrates presumably due to metabolism of diet-derived sugars (Figure 
5.3C). Conversely, the Nucleotide Sugar sub pathway in WT mouse liver was 
significantly decreased in the refed state possibly due to the fact certain nucleotide 
sugars are precursors for glycogen synthesis (Ball et al., 2011) (Figure 5.3D). In WT 
mice, hepatic lactate, a product of glycolysis, was significantly higher in the refed state 
(Figure 5.3E).  However, the upstream glycolysis intermediate, pyruvate was not 
significantly altered in response to feeding (Figure 5.3F).  
     Abcb6LKO and Abcb6LOE mice had no significant variations from WT mice in 
hepatic glucose, the Carbohydrate super pathway, Glycogen, Fructose/Mannose, 
Lactose, or Pyruvate sub pathways in either nutritional state. (Figures 5.3A, 5.1B, 5.3B, 
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5.3C, 5.3E, and 5.3F). However, several changes were seen in the Nucleotide sugars 
sub pathway. Although both Abcb6LKO and Abcb6LOE groups had increases in 
nucleotide sugars in response to fasting, only the Abcb6LOE group was statistically 
significant. Also, Abcb6LKO mice had significantly lower nucleotide sugars in the fasted 
state compared to WT. Finally, in the refed state, Abcb6LOE mice had significantly 
lower refed nucleotide sugar levels. 
     The carbohydrate super pathway and most carbohydrate sub pathways were 
increased in the refed state with virtually no differences in sub pathway levels or 
responses between any genetic treatment groups. The exception to this trend was a 
relative increase in nucleotide sugars in the fasted state in all groups with Abcb6LKO 














Figure 5.3. Metabolic Carbohydrate sub pathway changes in response to fasting and 
refeeding in WT, Abcb6LKO, and Abcb6LOE mouse liver (A)-(F) Peak values of glucose, 
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Glycogen, Fructose/Mannose/Galactose, and Nucleotide sugars sub pathways, lactate, and 
pyruvate. N=4.  
 
Energy Metabolites in Fasted and Refed Mouse Liver 
     In this analysis, the Energy super pathway is comprised of oxidative phosphorylation 
and tricarboxylic acid (TCA) cycle sub pathways. The Energy super pathway was not 
significantly altered in response to feeding in any of our treatment groups (Figure 5.1C) 
nor did the Abcb6LKO or Abcb6LOE group responses significantly differ from the WT 
group. However, several TCA derivative metabolites were significantly altered. In WT 
mice, the metabolite that had the highest magnitude of upregulation in response to 
feeding was succinyl carnitine (Figure 5.4A). Conversely, alpha-ketoglutarate was 
significantly decreased in the refed state (Figure 5.4B). These significantly altered 
intermediates may indicate cataplerotic/anaplerotic exit and entry points of the TCA 
cycle.  
     Abcb6LKO mice did not differ significantly from WT mice in the parameters listed 
above (Figures 5.1C, 5.4A, and 5.4B). Energy super pathway and succinyl carnitine 
levels were similar to WT and Abcb6LKO mice in Abcb6LOE mice. However, fasting did 
not illicit an increase in alpha-ketoglutarate (Figures 5.1C, 5.4A, and 5.4B). 
     The Energy super pathway was only very slightly decreased upon fasting in all 
treatment groups; supportive of the concept that the liver contributes to energy 














Figure 5.4 Metabolic Energy metabolite changes in response to fasting and refeeding in 
WT, Abcb6LKO, and Abcb6LOE mouse liver (A) Succinyl carnitine total peak values. (B) 
Pyruvate total peak values. N=4. 
 
Lipid Metabolites in Fasted and Refed Mouse Liver 
     At the start of the fasting period, blood lipid levels fall. Through beta-adrenergic 
signaling, free-fatty acids are liberated through lipolysis in adipose deposits and fatty 
acids are taken up by the liver. It is well established that as a result, total hepatic lipids 
are increased in the fasted state (Geisler, et al., 2016; Rui, 2014). Our analysis was in 
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accord, showing an increase in the Lipid super pathway in response to fasting in all 
treatment groups (Figure 5.1D). The free-fatty acids are either oxidized into ketones or 
packaged into VLDL particles for use by extrahepatic tissues. In WT mice, the 
Diacylglycerol sub pathway contributed to the greatest increase within the super 
pathway (Figure 5.5A). Long and medium chain fatty acid sub pathways were also 
significantly increased in the fasted state. (Figures 5.5B and 5.5C). Polyunsaturated 
fatty acids (n-3 and n-6) were also increased in the fasted state in keeping with 
previously published results (Figure 5.5D) (Marks et al., 2015). The increased hepatic 
fatty acid and diacylglycerol content was likely due to the well-characterized influx of 
adipose fatty acids due to increased lipolysis and hepatic fatty acid uptake. The Ketone 
and Oxidized fatty acid sub pathways were also significantly increased in the fasted 
state (Figures 5.5E and 5.5F). The increase in ketone bodies is intuitive due to the 
expected switch to utilization of lipids for energy in the fasted state. Oxidized fatty acids 
such as 4-hydroxynonenal (the sole metabolite assessed in this study) have been 
associated with increased beta-oxidation (Li et al., 2013). The Mevalonate sub pathway 
was also significantly increased in the fasted group (Figure 5.5G) in agreement with 
previously published data (Wiss et al., 1977) that describes increased cholesterol 
synthesis in the fasted state. The increase seen in mevalonate may be a compensatory 
action to increase endogenous cholesterol production in absence of an exogenous 
supply.  
     Despite the fasting-mediated increase of most hepatic lipids, WT 
glycerophospholipids were significantly increased in the refed state with the significant 
increases seen in phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
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phosphatidylinositol (PI) and phosphatidylglycerol (PG) (Figures 5.5H-5K). The relative 
decrease in hepatic phospholipid content due to fasting is consistent with published 
results (Ikeda et al., 2014). 
     An essential function of the liver is the production of bile acids which are the main 
component of bile (also containing cholesterol and phospholipids), a substance that aids 
in the intestinal absorption of fats and fat-soluble nutrients through its surfactant action 
on lipids. Primary bile acids originate from the liver while secondary acids are produced 
through bacterial reactions in the intestine. Primary bile acids from the liver are routed to 
the ileum through the common hepatic bile duct and are also stored in the gall bladder 
(in mice). Primary and secondary bile acids are reabsorbed from the intestinal lumen 
and returned to the liver through portal circulation. The total amount of bile acids 
existing this enterohepatic circulation is referred to as the bile acid pool. In WT mice, 
Primary and Secondary bile acid sub pathways had a slight, non-significant increase in 
response to feeding suggesting increased hepatic bile acid synthesis and a larger bile 
acid pool. (Figures 5.1D, 5.5L, and 5.5M)This response is in agreement with published 
data (Chiang, 2013).  
     Hepatic diacylglycerol and fatty acid fasting-induced increases in Abcb6LKO and 
Abcb6LOE mice were similar to WT mice (Figures 5.5A-5D). Likewise, oxidized fatty 
acids and beta-hydroxybutyrate levels were increased in response to fasting in both 
Abcb6LKO and Abcb6LOE mouse liver. However, in Abcb6LKO and Abcb6LOE mice, 
fasting beta-hydroxybutyrate was lower compared to the WT group with the Abcb6LOE 
group reaching statistical significance. Also, both Abcb6LKO and Abcb6LOE mouse 
liver had lower oxidized fatty acids in the fasted state compared to the WT groups but 
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the decrease did not reach statistical significance (Figures 5.5E and 5.5F). The 
Abcb6LKO and Abcb6LOE Mevalonate sub pathway levels increased in response to 
fasting as was the case in the WT group. However, both Abcb6LKO and Abcb6LOE 
fasted levels were significantly lower as compared to WT (Figure 5.5G). Feeding 
induced glycerophospholipids in a similar manner in Abcb6LKO and Abcb6LOE mice 
with the exception being the Abcb6LOE Phosphatidylcholine sub pathway which was 
not significantly increased in response to feeding (Figures 5.5H-5K). In contrast to the 
slight feeding-induced increase in bile acids seen in WT mice, the Abcb6LKO group 
refed levels were virtually identical to fasted state levels. Remarkably, Abcb6LOE mice 
had an opposite response compared to the WT group with relatively lower bile acids in 
the refed state with the fasted levels being significantly higher than both WT and 
Abcb6LKO groups (Figures 5.5.L and 5.5.M).  
     In summary, hepatic lipids were generally increased in the fasted state except for 
glycerophospholipids which were decreased in response to fasting in WT mice. 
Products of fatty acid oxidation are also increased in WT mice in the fasted state. 
Abcb6LKO and Abcb6LOE mice had blunted fasting-induced beta-oxidation and 
cholesterol responses as compared to WT. Finally, genetic manipulation of ABCB6 





















































Figure 5.5. Metabolic Lipid sub pathway changes in response to fasting and refeeding in 
WT, Abcb6LKO, and Abcb6LOE mouse liver (A)-(M) Total peak values in the diacylglycerol, 
long chain, medium chain, and polyunsaturated fatty acid, ketone, oxidized fatty acid, 
mevalonate, PC, PE, PI, PG, primary bile acid, and secondary bile acid sub pathways N=4.  
 
Nucleotide Metabolites in Fasted and Refed Mouse Liver 
     The liver is the main site of nucleotide biosynthesis through the salvage and de novo 
synthesis pathways (Fustin et al., 2012). Integral to all biological functions, they are 
found in energy molecules such as adenosine triphosphate (ATP), cofactors such as 
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flavin adenine dinucleotide (FAD), and nucleic acids in DNA and RNA. In WT mice, the 
Nucleotide super pathway was decreased in the refed state (Figure 5.1E) but the overall 
decrease did not reach statistical significance. Purine sub pathways in WT mice were 
decreased in response to feeding with the Adenosine and Inosine/Xanthine sub 
pathways reaching statistical significance (Figures 5.6A-6C). Pyrimidines in the 
Cytidine, Thymine, and Uracil sub pathways were also significantly decreased in the 
refed state in the WT group. The Orotate sub pathway was the exception to this 
downward trend in the fed state with this pyrimidine precursor being significantly 
increased in response to feeding (Figures 5.6D-6G). The overall trend of increased 
nucleotides in the WT fasted mice may be consistent with published data that indicate 
increased glucagon induces RNA degradation to yield an overall increase in nucleotides 
(Bleiberg-Daniel et al., 1994).  
     Purine metabolites in Abcb6LKO group followed the same general trend as WT 
except that Abc6LKO mice had no significant increase in the Adenine sub pathway 
(Figures 5.1E and 5.6A-6C). In the Abcb6LOE group, the fasting mediated increase in 
the Nucleotide super pathway as well as Purine sub pathways reached statistical 
significance (Figures 5.1E and 5.6A-6C). Also, Abcb6LOE mice had significantly lower 
Guanine sub pathway levels compared to WT mice (Figure 5.6B). As in the WT group, 
Abcb6LKO and Abcb6LOE mice had lower levels of most pyrimidine sub pathway levels 
in the fed state with the Abcb6LOE group reaching significance. As in the WT group, the 
Orotate sub pathway was increased in the refed state for both Abcb6LKO and 
Abcb6LOE mice. However, Abcb6LKO and Abcb6LOE mice had lower refed orotate 
levels compared to WT with the Abcb6LKO group reaching statistical significance 
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(Figures 5.6D-6G). In the Uracil pyrimidine sub pathway, Abcb6LOE mice had 
significantly lower levels in the refed state compared to Abcb6LKO (Figure 5.6F).  
      Purines and pyrimidines (Nucleotide super pathway) increased in the fasted state 
with respect to the refed state except for the pyrimidine precursor, orotate which 
displayed an opposite trend. This trend was true for all treatment groups with orotate 
levels being lower in the Abcb6LKO and Abcb6LOE groups compared to WT in both 
nutritional states. Because orotate is a precursor to de novo pyrimidine synthesis, it is 






















Figure 5.6. Metabolic Nucleotide sub pathway changes in response to fasting and 
refeeding in WT, Abcb6LKO, and Abcb6LOE mouse liver (A)-(G) Total peak values in the 
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Adenine, Guanine, Inosine/Xanthine, Cytidine, Thymine, Uracil, and Orotate sub pathways. 
N=4.  
 
Peptide Metabolites in Fasted and Refed Mouse Liver 
     Peptides are oligomers of linked amino acids formed from the degradation of 
proteins (Fruton et al., 1950). The source for peptides may be the proteolysis of 
endogenous proteins or they may be derived from diet. Peptides from a meal may be 
delivered to the liver from enterocytes through portal circulation where they are broken 
down through extracellular hydrolysis (Lochs et al., 1986) for the delivery of amino 
acids. Hepatic lysosomes are they main source of endogenous peptides through protein 
degradation (Thamotharan et al., 1997). In WT mice, feeding produced a slight, albeit 
non-statistically significant increase in the peptide super pathway (Figure 5.1F). Both 
the Dipeptide and Gamma-glutamyl sub pathways were increased in response to 
feeding with the Dipeptide sub pathway reaching statistical significance (Figures 5.7A 
and 5.7B). The increase in gamma-glutamyl peptides indicates an increase in the 
gamma-glutamyl transferase activity which regulates the gamma-glutamyl cycle 
(Orlowski et al., 1976) and the increase in that sub pathway is in accordance with the 
increase in glutathione seen in the amino acid super pathway in WT mouse liver (Figure 
5.1A). 
     Abcb6LKO mice were not significantly different from WT in the Peptide super 
pathway nor either sub pathway (Figures 5.1F, 5.7A, and 5.7B). Abcb6LOE mice 
however, had an opposite trend in the Peptide super pathway with a fasted mediated 
increase though not reaching statistical significance (Figure 5.1F). The same trend was 
seen in both sub pathways in Abcb6LOE mice although not reaching statistical 
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significance (Figures 5.7A and 5.7B). However, refed Abcb6LOE levels of both sub 
pathways were lower than WT and Abcb6LKO mice with the dipeptide sub pathway 
reaching statistical significance (Figures 5.7A and 5.7B). 
     In summary, peptides were increased in response to feeding in WT and Abcb6LKO 
mice with both sub pathways also being increased in the refed state. However, 
Abcb6LOE mice showed the opposite trend with an increase in the fasted state. This 
result correlates well with the previously data showing a relatively blunted glutathione 
response to feeding seen in the Abcb6LOE group because gamma-glutamyl peptides 









Figure 5.7 Metabolic Peptide sub pathway changes in response to fasting and refeeding 
in WT, Abcb6LKO, and Abcb6LOE mouse liver (A) Total peak values in the Dipeptide sub 
pathway. (B) Total peak values in the gamma-glutamyl sub pathway. N=4.  
 
Vitamin Metabolites in Fasted and Refed Mouse Liver 
     Vitamins and cofactors are essential for crucial enzymatic functions. While some 
vitamin levels can be maintained through endogenous biosynthesis, like humans,  mice 
are reliant upon diet-derived biochemicals for survival (1995). In the WT group, the 
Vitamin super pathway was significantly increased in the fed state (Figure 5.1G). 
Interestingly, there were several vitamin sub pathways that were significantly reduced in 
the fed state including Folate, Riboflavin, Vitamin B6, and Thiamine sub pathways 
(Figures 5.8A-8D) even though the standard diet used for this study included the 
biochemicals from these sub pathways. The Vitamin A, Vitamin E (tocopherol), and 
Pantothenate/ CoA sub pathways were significantly increased in response to feeding 
(Figures 5.8E-8G). The decreases seen in some sub pathways could be due to hepatic 
transport and metabolism at the time-point chosen for this study. 
     In Abcb6LKO mouse liver, the Vitamin super pathway was also significantly 
increased in response to feeding. However, Abcb6LOE mice had a slight (non-
significant) decrease of the Vitamin super pathway in the fed state (Figure 5.1G). In the 
vitamin sub pathways that were decreased in response to feeding in the WT group 
(Folate, Riboflavin, Vitamin B6, and Thiamine), Abcb6LKO and Abcb6LOE mice also 
had lower levels in the refed state (Figures 5.8A-8D). With the only notable alteration 
being that Abcb6LOE mice had a slight but significant increase in the Thiamin sub 
pathway in the fasted state compared to Abcb6LKO mice (Figure 5.8D). In the vitamin 
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sub pathways that were increased in response to feeding in the WT group (Vitamin A, 
and Vitamin E (tocopherol), Pantothenate/ CoA), Abcb6LKO and Abcb6LOE mice also 
showed the same increased trend in response to feeding (Figures 5.8E-8G). However, 
Abcb6LOE mice had drastically lower refed values in the refed state compared to WT 
and Abcb6LKO mice (Figures 5.8E-8G). The lower values in these sub pathways 
contributed to the significantly lower refed Abcb6LOE values in the Vitamin super 
pathway.  
     The Vitamin super pathway included the Heme sub pathway in which, heme was the 
sole metabolite. ABCB6 has been shown to be involved in heme biosynthesis in vitro 
(Krishnamurthy, et al., 2006) but in vivo studies suggest that ABCB6 expression is 
dispensable for heme production (Chavan, et al., 2015; Helias, et al., 2012). In this 
study, there was no significant difference in hepatic heme levels in Abcb6LKO or 
Abcb6LOE mice in either nutritional state. However, in WT mice heme was slightly 
elevated in response to feeding while in Abcb6LKO and Abcb6LOE mice, the was a 
slight decrease in the refed state (Figure 5.8H). Interestingly, Vitamin A and Vitamin E 
sub pathway level changes in the refed state seemed to follow the heme levels seen in 
the refed state. Published data suggests that hepatic levels of vitamins A and E are 
positively influenced by dietary iron (a component of the standard diet used for this 
study) (Domitrovic et al., 2008).  
     In summary, vitamins were differentially affected by feeding with increases seen in 
some sub pathways and decrease seen in others. The major difference between the 
treatment groups in this pathway was Abcb6LOE mice tended to have lower increases 




















Figure 5.8 Metabolic Vitamin sub pathway changes in response to fasting and refeeding 
in WT, Abcb6LKO, and Abcb6LOE mouse liver (A)-(H) Total peak values in the Folate, 
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Riboflavin, Vitamin B6, Thiamine, Vitamin A, Vitamin E, Pantothenate/CoA, and Heme sub 
pathways. N=4.  
 
Xenobiotic Metabolites in Fasted and Refed Mouse Liver 
     Xenobiotics are by definition, exogenous compounds received from environmental 
sources such as food, water, and air. The liver is the major organ involved in 
metabolizing xenobiotics as it receives ingested materials from the alimentary tract via 
portal circulation. As expected, feeding significantly increased the Xenobiotic super 
pathway in WT mouse liver (Figure 5.1H). Food and Benzoate sub pathways were also 
both significantly increased in response to feeding (Figure 5.9A and 5.9B). Compounds 
in the Benzoate sub pathway included 3-phenyl propionate and hippurate that are 
known metabolites from gut microbiota (Gautam et al., 2015). Feeding-induced 
stimulation of intestinal microbe metabolism likely explains the drastic increase in these 
biochemicals in the (Figures 5.9C and Figures 5.9D).  
     Xenobiotics were increased in response to feeding for all groups with the Abcb6LOE 
again having a less drastic increase in response to feeding as compared to WT with the 
Abcb6LKO group showing the opposite trend (greater magnitude of increase in the 















Figure 5.9 Metabolic Xenobiotic sub pathway changes in response to fasting and 
refeeding in WT, Abcb6LKO, and Abcb6LOE mouse liver (A) Total peak values in the Food 
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sub pathway. (B) Total peak values in the Benzoate sub pathway. (C) Peak values of phenyl 
propionate. (D) Peak values of hippurate. N=4.  
 
5.5 Discussion 
     Metabolic inflexibility plays an important role in the development of metabolic 
disease. Hepatic physiological responses to fasting and feeding are crucial to 
maintaining appropriate adaptation to nutritional status. Here, we present analysis of 
liver metabolites in fasted and refed states in WT, Abcb6LKO, and Abcb6LOE mice.   
     Because the liver receives macromolecules from portal circulation in the post-
absorptive state, an increase in most hepatic metabolic super pathways would be 
expected. Indeed, we saw increases in 6 out of 8 super pathways in WT and Abcb6LKO 
mice in response to feeding. Interestingly, in Abcb6LOE mice, only 4 out of 8 super 
pathways were increased in response to feeding.  
     This study’s analysis of hepatic metabolites reinforced previously established 
general maxims regarding physiological responses to fasting and feeding such as 
glycogen depletion, increased hepatic lipid uptake, and increased ketone production 
during a fast and increased hepatic carbohydrates and xenobiotics in response to 
feeding. 
     This set of data provides the first, to our knowledge, benchmark levels for hepatic 
metabolites in fasted and refed mice fed a standard chow diet. In the future, this study 
may be utilized to compare metabolite levels in other metabolic studies such as diet 
induced obesity or other dietetic alterations as well as genetic treatments effecting 
hepatic metabolism.  
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    With respect to the genetic treatment groups (Abcb6LKO and Abcb6LOE) used in this 
study. The most striking departures from the WT group were seen in amino acid and 
lipid metabolism. As previously mentioned, dipeptides can be imported and degraded to 
generate hepatic amino acid supply. In our study, disruption of ABCB6 expression 
lowered select hepatic dipeptides and amino acids. Members of the ABC transport 
super family have been shown to be involved in the transport of dipeptides and amino 
acids. (Vasiliou, et al., 2009; Young et al., 2001). Future studies could explore the 
possible transport dipeptide or amino acid transport function of ABCB6.  
     Cholesterol is the required substrate for bile acid synthesis. We found that genetic 
manipulation of ABCB6 resulted in lower hepatic cholesterol and bile acid levels and 
altered responses to feeding in these sub pathways. Again, published data indicates 
that ABC transporters play important roles in bile acid and cholesterol metabolism 
(Borst, et al., 2000) so it is conceivable that ABCB6 could have a transport function in 
either cholesterol or bile acid homeostasis.  
     There were relatively modest changes in phospholipid levels in Abcb6LKO and 
Abcb6LOE mouse liver compared to WT. Previous data demonstrates that Abcb6LKO 
and Abcb6LOE mice have altered mitochondrial morphology. It is likely that these 
changes are accompanied by altered mitochondrial membrane composition that may 
contribute to phospholipid changes seen in the whole lysate used for this study. Future 
analysis of isolated mitochondrial would be useful in pinpointing the source of altered 
phospholipids seen in this model. 
     Disruption of any one of the drastically altered pathways mentioned here could 
possibly explain our observation of metabolic inflexibility in Abcb6LKO and Abcb6LOE 
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mice. This study has provided a roadmap for future studies that will result in increased 
understanding of the contribution of ABCB6 to mammalian physiology. Supplemental 
assays such as RNA sequencing and mitochondrial metabolomics will direct future 
studies involving the potential role of ABCB6 in lipid and amino acid metabolism and will 




     The present study is a “snap-shot” of both nutritional states (18 hour fasted, and 6 
hours refed). Time course evaluation of both states would be informative regarding 
physiological responses. The liver plays an important role in whole-body metabolic 
flexibility, but additional studies of major metabolic organs would provide a more 
complete picture of the responses necessary to maintain energy homeostasis. Further, 





































     This dissertation provides a detailed description of the metabolic consequences of 
altered ABCB6 expression in mice. The present studies show that ABCB6 deficiency or 
overexpression has a profound impact on energy homeostasis which is associated with 
changes in mitochondrial form and function. Despite previous in vitro and ex vivo data 
that suggested ABCB6 was associated with heme biosynthesis, multiple experiments 
determined that ABCB6 ablation or overexpression did not result in significant changes 
in heme levels in vivo. Therefore, the phenotypes described here are independent of 
changes in heme biosynthesis.  
 
Chapter 2 Prior to this study, ATP-binding cassette transporter, ABCB6 was shown to 
be involved in the heme biosynthesis pathway in cell-based models (Krishnamurthy, et 
al., 2006). Additional studies confirmed that loss of ABCB6 is associated with several 
mammalian pathologies such as ocular coloboma, familial pseudo hyperkalemia, and 
atherosclerosis (Andolfo, et al., 2013; Murphy, et al., 2014; Wang, et al., 2012). 
Because these conditions have not been found to be directly linked to a disruption in 
heme synthesis, it is probable that ABCB6 has additional non-heme related 
physiological functions.  
     To better understand ABCB6 function in vivo, we utilized a whole-body Abcb6 
knockout mouse model. We observed metabolic disturbances in homozygous Abcb6 
whole-body knock-out in male and female mice. Suggestive of a role in development, a 
portion of Abcb6 KO offspring had stunted growth. Over time, these smaller mice 
surpassed wild-type liter mates in body weight despite no difference in food 
consumption. We discovered that the increased body mass was due to increased 
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adipose tissue. The obesogenic phenotype was accompanied by lower energy 
expenditure, metabolic syndrome-like characteristics such as disrupted glucose 
metabolism and disturbances in pathways that regulate energy homeostasis. 
Interestingly, through these studies, we discovered that hepatic ABCB6 expression is 
suppressed in obesity. Through EM imaging and bioenergetic flux assays, we found that 
ABCB6 deficiency resulted in increased fragmentation and decreased function in 
hepatic mitochondria. These results lead to the hypothesis that the metabolic 
disturbances in whole-body KO mice were due to ABCB6-mediated mitochondrial 
alterations.  
     Most of the analysis of mitochondrial form and function was done in liver. However, 
because the driving force of the obesogenic phenotype is likely due to reduced energy 
expenditure and physical activity, analysis of other tissues that regulate this aspect 
should be performed in the future. Endocrine system components such as the 
hypothalamus, thyroid, and pituitary contribute to overall energy balance and activity. 
Along with skeletal muscle and the brain, macro and micro anatomical analysis as well 
as mitochondrial form and function studies of these tissues in Abcb6 KO mice would 
possibly result in a better understanding of origins of the observed phenotype.  
     Because the disruption of mitochondrial morphology and function was observed prior 
to the onset of obesity, it seems clear that mitochondrial dysfunction precedes metabolic 
syndrome in this model. However, it is presently unclear at what timepoint mitochondrial 
changes occur. Earlier observations of possible embryonic lethality seem to suggest 
that alteration of ABCB6 expression would have a developmental impact.  At what point 
do mitochondrial abnormalities occur in Abcb6 KO mice and if in early development, 
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how does this contribute to the metabolic syndrome seen in adulthood are still open 
questions. A full developmental study of Abcb6 KO mice could partially address these 
questions. Additionally, because we currently have an Abcb6 “floxed” mouse model, it is 
possible to alter ABCB6 expression using a universal promoter creating a whole-body 
KO or over expressing mouse after development is complete via intraperitoneal delivery 
of AAV8 Cre virus under a universal promoter. The combination of these two studies 
would give a clearer picture of how ABCB6 expression influences development and 
contributes to energy homeostasis in adulthood in absence of generational or 
developmental effects.  
 
Chapter 3 The maintenance of whole-body energy homeostasis involves extensive 
inter-organ crosstalk. Also, we currently don’t fully understand the developmental or 
generational consequences of ABCB6 deletion. Although ABCB6 is expressed in all 
metabolic tissues, it is unknown whether this transporter has tissue-specific functions. 
These facts represented barriers to unraveling the mechanistic details of ABCB6-
mediated homeostatic disruptions in whole-body KO mice. To overcome these 
impediments, we developed a tissue-specific, inducible system to control ABCB6 
expression. This chapter discusses the phenotypes seen due to liver-specific deletion or 
overexpression of ABCB6 in 8-week male mice.  
     Following up on the mitochondrial dysfunction seen in Abcb6 whole-body knockout 
mice, we confirmed that liver-specific alteration of ABCB6 also resulted in mitochondrial 
morphological changes with Abcb6LKO having increased fragmentation and Abcb6LOE 
having increased elongation in their respective mitochondrial populations. We also 
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discovered that function followed form in this model with fragmentation being associated 
with decreased mitochondrial function and elongation resulting in increased function in 
Abcb6LKO and Abcb6LOE mice respectively.  
     Based upon the previous observation that ABCB6 expression is downregulated in 
the obese state and the known association between mitochondrial dynamic changes in 
response to nutrient status, we investigated ABCB6 hepatic expression patterns in 
response to the diurnal feeding cycle. We found that ABCB6 expression was 
upregulated in low-nutrient (fasted) state and downregulated in high-nutrient (post-
absorbent) state mirroring the mitochondrial morphology and function seen in the 
Abcb6LOE and Abcb6LKO models respectively. 
     In Abcb6LKO mouse liver, the expression of mitochondrial fusion proteins was 
decreased while fission protein expression was increased. In Abc6LOE mouse liver 
fusion protein expression was increased, and fission proteins were downregulated. This 
data supported the hypothesis that ABCB6 is responsive to nutrient signals and 
mediates a homeostatic response via interaction with mitochondrial fission and fusion 
machinery thus regulating metabolic flexibility. Indeed, Abcb6LKO and Abcb6LOE mice 
have altered food consumption and respiratory exchange ratio in response to dietary 
challenges as compared to wild-type mice as measured by indirect calorimetry assays. 
The loss of metabolic flexibility in Abcb6LKO and Abcb6LOE mice resulted in abnormal 
hepatic lipid and carbohydrate metabolism as well as disrupted glucose and insulin 
signaling. This study illustrates that ABCB6 plays a crucial role in maintaining energy 
homeostasis as suggested in the Abcb6 whole-body KO studies. Remarkably, either 
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knockdown or overexpression of ABCB6 in a single organ, the liver, manifested 
systemic metabolic syndrome-like characteristics.  
     Future studies are needed to understand the mechanisms by which nutrient status 
influences ABCB6 expression and the downstream effects of this transporter’s 
regulation. Our previous studies showed that ABCB6 expression was post-
translationally downregulated by acute or chronic high nutrient status. Therefore, it is 
likely that ABCB6 degradation pathways are dynamically activated in response to 
increased nutrient supply. Inhibition of selected protein degradation pathways could 
uncover details of how nutrient sensing pathways are linked to the rapid regulation of 
ABCB6 expression.  
     Chapter 3 describes phenotypes seen after a set time point after genetically altering 
ABCB6 expression (10 days post IP delivery of AAV8 virus). It would be informative to 
discover the rapidity of mitochondrial morphological/functional changes in response to 
the loss or gain of ABCB6 expression. Such experiments could include analysis of 
ABCB6 expression and mitochondrial form and function as early as 24 hours post-
injection and tracking those changes up to the 10 day point previously studied. 
Alternatively, it would be interesting to discover if the severity of the 10-day phenotypes 
would be more drastic after a longer period of ABCB6 knockdown/overexpression or 
conversely, would compensatory responses overcome the metabolic disturbances seen 
in this study. Any observable compensatory responses would no doubt, be informative.  
     Because the liver is crucial maintaining whole-body energy homeostasis and 
because ABCB6 is highly expressed in the liver, we chose this organ as the first tissue-
specific study.  However, crosstalk between the liver and other metabolic organs is well 
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documented and this study did not fully explore the effects of hepatic alteration of 
ABCB6 in other tissues. Changes in ectopic lipid accumulation, fuel selection in non-
hepatic tissues, adipose hypertrophy or biogenesis, and hormonal responses are just a 
few examples of non-hepatic aspects that could be explored using this model. 
Information gained using this approach could shed further light upon the role of ABCB6 
in maintaining energy homeostasis.  
     In addition, ABCB6 is also highly expressed in other tissues. Adipose, pancreas, 
muscle, testes, and brain-specific viruses are commercially available by which, further 
studies could explore the impact of changing ABCB6 expression in these tissues. Would 
gain or loss of ABCB6 have the same mitochondrial effects in these tissues? If so, what 
would be the impact on energy metabolism and other metabolic tissues in which ABCB6 
expression was not targeted? Since the physiological role of ABCB6 in mammals is 
unclear, is it possible that ABCB6 expression could have differential functionality based 
upon specific organs or tissues. For example, ABCB6 is highly expressed in testes. 
Would genetic alteration of ABCB6 testicular expression affect fertility? Based upon the 
lower than expected homozygous progeny seen in our whole-body Abcb6 knockout 
mice, this is a worthy question. We also observed behavioral abnormalities in the whole-
body knock out model. Because the nervous system is highly reliant on mitochondrial 
function and appetite control is an essential function of the brain, behavioral and 
metabolic studies using an Abcb6 brain-specific model are likely warranted.  
     The temporal and tissue-specific control of gene expression is a powerful tool. In our 
model, we also can accurately assess spatial and tissue-specific expression of ABCB6 
through LacZ/ X Gal staining. Comprehensive analysis of the tissue-specific effects of 
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changes in ABCB6 expression, compensatory ABCB6 expressional changes by non-
targeted tissues, and differential ABCB6 expression patterns will provide crucial 
information needed to understand ABCB6 function in higher eukaryotes.  
 
Chapter 4 details global metabolomic data from the livers of wild-type, Abcb6LKO, and 
Acb6LOE mice in fasted and refed states. The purpose of this study was two-fold. 
Firstly, changes in liver metabolites in response to fasting or feeding are descriptive of 
hepatic adaptive responses to nutrient status that are not yet fully understood. Because 
this is the first murine study under these conditions, we needed to establish baseline 
levels of metabolites in wild-type mouse as well as the change in these levels in 
response to nutrient status. Secondly, Abcb6LKO and Abcb6LOE mice exhibit 
metabolic inflexibility. We proposed that metabolomic analysis of mice in this model 
would be informative as to possible transport substrates and functions of ABCB6 in 
mouse liver.   
     Our WT metabolomic study re-enforced previously well-characterized hepatic 
adaptations to fasting and feeding such as increased lipid import and glycogenesis. The 
study also reveals less understood adaptations. In our study, select vitamins were 
increased upon feeding while others were decreased in the refed state. Also, previous 
studies have shown that hepatic lactate is increased in liver in the fasted state, but our 
study shows higher lactate levels in the refed state.  
     Abcb6LKO and Abcb6LOE mice had significant changes in amino acid/peptide, 
nucleotide, and lipid metabolism. Additional studies and additional analysis of the 
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metabolite study will likely aid in pinpointing how ABCB6 expression relates to metabolic 
flexibility. 
     Although this study was informative, future studies will greatly enhance the value and 
usefulness of this data. Since many metabolites analyzed in this study could originate 
from either exogenous sources (food) or endogenous metabolic pathways, it is 
impossible to discern whether some metabolite level changes are attributable to the 
intake of a particular metabolite (or parent compound further metabolized to the final 
metabolite), or from regulatory actions of endogenous pathways. Another complication 
involved in these studies is that some pathways share a common metabolite. It is 
conceivable that opposing physiological adaptations could increase a common 
metabolite thus confounding the ability to conclude which metabolic action is causative 
of the metabolite level change. A parallel RNA sequencing analysis would assist in 
resolving both issues. RNA sequencing would provide a detailed transcriptional picture 
in both nutritional states thus potentially allowing us to conclude through pathway 
analysis if level changes were of endogenous origins and from which metabolic 
response/s they arose.  
     Our metabolomic study was performed on liver tissue whole lysate.  Additional 
analysis of isolated mitochondria from the same treatment groups would be beneficial in 
several aspects. Previous publications have suggested multiple sub cellular 
localizations for ABCB6. Analysis of the mitochondrial fraction would highlight metabolic 
disturbances associated with the mitochondrial form of ABCB6. Both this metabolomic 
and our previous studies suggest dramatic lipid metabolism alterations in this model.  
Cellular membrane content contributes substantially to the overall lipid profile of the 
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liver. Our previous data show drastic morphological changes in Abcb6LKO and 
Abcb6LOE mitochondria which are very likely accompanied by alterations in membrane 
composition. Performance of metabolomic analysis on the mitochondrial fraction would 
improve the resolution of mitochondrial lipid changes and possibly identify lipid-related 
mechanistic details of how mitochondrial dynamics are affected in our model. 












































Animal Studies— All animal experiments were approved by the University of Kansas 
Medical Center Institutional Animal Care and Use Committee. Mice were housed in 
polycarbonate cages (four per cage) and maintained on a 14-h/10-h light-dark cycle at 
22 5 °C and 20% relative humidity. For Abcb6 whole-body knock out studies, mice were 
provided standard chow diet and water ad libitum. Mice were fasted for 12 hours prior to 
tissue collection.  
      For liver-specific studies, mice were entrained to time-restricted feeding (food 
provided from 7:30 pm to 7:30 am only) for one week prior to tissue collection. Fasted 
groups were fasting for 18 hours. Refed groups were fed for six hours prior to collection. 
Water provided ad libitum. 
 
Abcb6 Whole-Body Null Mice—Abcb6 knock-out mice were generated on C57BL6/N 
background using ES cells developed by the trans-NIH Knock-Out Mouse Project. The 
ablation cassette (velocigene cassette [bacterial J3-galactosidase-polyadenylation 
signal-loxP (locus of X over P1) site-human ubiquitin C gene promoter-neomycin 
phosphotransferase-polyadenylation sig- nal-loxP site]) used to generate Abcb6 knock-
out mice replaces the Abcb6 ORF containing exons 3–5 with the J3-galactosidase- 
hUBC/em7-neomycin-poly(A) cassette, where the neomycin expression cassette is 
flanked by loxP sites (24). Microinjection of ES cells and generation of Abcb6 
heterozygous mice were done according to standard procedures. Mice were genotyped 
using appropriate primers. The first primer pair anchors to exon 1 and exon 3 and 
amplifies 470 bp of the WT allele. The sequences of the primers are as follows: WT-F, 
5'- GCCCCCAGTCTTATACTCTA- CACG-3', and WT-R, 5'-
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CCCATGCCTCTCTCTGCTTTCC- 3'. The second primer pair anchors to exon 1 and 
the neomycin cassette and amplifies 620 bp of the mutant allele. The primer sequences 
are as follows: KO-F, 5'-CACACCTCCCCCTGAACCTGAAA-3', and KO-R, 5'-CGT- 
GACCCCTCTCAGAGTTAGGAAAG-3'). 
Weight recordings- For body weight analysis, animals on a regular chow diet (Harlan 
Teklad 2018; 18% calories from fat) or, when indicated, an HFD (Research Diets 
D12451; 45% of total calories from fat) were weighed at the indicated time points from 
week 5 till week 20. Food intake was measured daily for the entire duration of the study 
and was determined to the nearest 0.1g by weighing the remaining chow or HFD. 
Trained personnel performed weekly observations of all mice.  
ECHOMRI- Quantitative Magnetic Resonance (ECHOMRI 1100) measurements were 
made were done on mice that were fed ad lib during the light phase (0900 hr.). Scans 
were performed by placing animals into a thin-walled plastic cylinder (1.5 mm thick, 4.7 
cm inner diameter), with a cylindrical plastic insert added to limit movement. While in the 
tube, animals were briefly subjected to a low-density (0.05 Tesla) electromagnetic field 
to measure fat, lean mass, free water, and total body water. The general theoretical 
background and specific technical details describing the basic functionality of this 
system is well-described by Tinsley et al (Evaluation of a quantitative magnetic 
resonance method for mouse whole body composition analysis. Tinsley FC, Taicher GZ, 




Generation of genetically modified Abcb6 Liver-Specific mice- Abcb6LKO and 
Abcb6LOE mice were generated on a C57BL6/N background. The strategy for the 
generation of genetically modified Abcb6 mice is shown in Figure 3.1A. Mice were 
maintained on a 12 h dark/light cycle and housed in groups of two to four with unlimited 
access to water and chow diet (5053 PicoLab Rodent diet 20, Fort Worth, TX) as indicated 
for individual experiments. All animal procedures were performed in accordance with the 
Guide for Care and Use of Laboratory Animals of the NIH and were approved by the 
Institutional Animal Care and Use Committee of the University of Kansas Medical Center, 
Kansas. In this report all animal studies were done using male mice. 
 
Production of Adeno Associated Viral (AAV) Particles- Purified AAV-TBG-PI-Cre and 
AAV-TBG-PI.eGFP viral particles were obtained from Penn Vector Core (University of 
Pennsylvania, Philadelphia, PA). Purified AAV-TBG-PI-Abcb6 and AAV-TBG-PI.eGFP 
(Abcb6 control) viral particles were obtained from Vector Biolabs (Malvern, PA). 
 
Postprandial mouse model. The strategy for the postprandial mouse is shown in 
Supplementary Figure 4A. Briefly, For ABCB6 expression studies, male mice (C57BL6/N) 
were trained to handling, and night time feeding and day time fasting for a period of 9 
days to minimize variability linked to stress and food consumption.  On the 10th day mice 
were moved to fresh cages and grouped into mice that were scheduled to be fasted or 
mice that were scheduled to be fed. On the 10th night mice scheduled to be fed were 
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given food for 6 h, while mice scheduled to be fasted were not given any food. At the end 
of 6 h feeding mice in all groups were sacrificed and liver biopsy and/or harvest followed.  
     For fed and fasted responses of genetically modified Abcb6 mice studies Abcb6flox/flox 
male mice 5 weeks of age were given a single peritoneal injection of either AAV8-TBG-
PI. Cre or AAV8-TBG-PI-eGFP or AAV8-TBG-PI-Abcb6. Injected mice were then trained 
to handling and night time feeding and day time fasting for a period of 9 days to minimize 
variability linked to stress and food consumption. On the 10th day mice were moved to 
fresh cages and grouped into mice that were scheduled to be fasted or mice that were 
scheduled to be fed. On the 10th night mice scheduled to be fed were given food for 6 h, 
while mice scheduled to be fasted were not given any food. At the end of 6 h feeding mice 
in all groups were sacrificed and liver biopsy and/or harvest followed.  
 
Circadian mouse model. The strategy for the circadian rhythm is shown in Figure 3.4B. 
Briefly, mice were housed in barrier facilities with 12 h light and dark cycles. ZT0: lights 
on at 6 am; ZT12: lights off at 6 pm. Mice were fed ad libitum with chow diet (5053 PicoLab 
Rodent diet 20, Fort Worth, TX). For circadian studies male mice C57BL6/N 5 - 6 week 
of age were sacrificed every 3 hours for 24 hr. Liver tissue was harvested and was used 
to isolate RNA. RNA samples were used to analyze circadian oscillation of Abcb6 
transcript while total liver lysates were processed and used to analyze circadian 
oscillation of ABCB6 protein.   
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Hepatic H & E staining- Mouse liver sections were rinsed in phosphate buffered saline 
and immediately fixed in buffered 10% formaldehyde for 48 hours followed by a 24-hour 
incubation in 70% ethanol. Tissues were then processed for 6 hours in a Leica 
ASP300S tissue processor. Paraffin-embedded tissues were sectioned to 6uM and 
stained with hematoxylin and eosin and imaged with an Olympus DP71 microscope. 
 
Oil O Red Staining- Liver sections were collected and embedded in embedding 
medium. (Tissue-Tek® O.C.T. Compound, SAKURA, USA) and frozen on dry ice. 
Frozen sections (6 mm thick) were cut in a cryostat and stained with oil red O and 
hematoxylin for studying lipid accumulation with an Olympus DP71 microscope. 
 
Periodic Schiff stain- Glycogen was visualized in paraffin-embedded tissue sections 
using a periodic acid – Schiff (PAS) staining kit (Sigma Aldrich, St Louis, MO). Tissue 
sections were also stained with standard hematoxylin and eosin for general cell 
morphology. 
 
Lipid and metabolite Analysis- Hepatic and serum ketones, triglyceride, free fatty 
acid, and total cholesterol were determined using BioVision Incorporated (155 South 




Preparation of tissue lysates - Mouse liver lysates were prepared as follows. 
Approximately, 0.05 grams (wet weight) of frozen tissue was homogenized in 500uL 1X 
Ripa buffer (Thermo Scientific, Waltham, MA) with protease inhibitors (Roche Applied 
Science) using a glass dounce homogenizer on ice. The resulting solution was spun at 
10,000 g for 10 minutes at 4 degrees Celsius in a tabletop centrifuge. The supernatant 
was then collected and following BCA protein estimation, mixed with 4X Laemmli buffer 
(Bio-Rad 161-0747) and 1:100 beta mercaptoethanol. 
Immunoblotting- Approximately 50 𝜇g of total protein was analyzed by polyacrylamide 
gel electrophoresis (PAGE). Commercial primary antibodies were used for relative 
protein detection. Immunoreactive proteins were detected by using polyclonal goat anti-
rabbit or anti-mouse horseradish peroxidase IgG secondary antibodies (Thermo 
Scientific, Waltham, MA) and visualized using Supersignal chemiluminescent 
horseradish peroxidase substrate (Thermo Scientific, MA) or IRDye goat anti-
rabbit/goat-anti-mouse secondary antibodies (Li-Cor Lincoln, NE, USA) and visualized 
by Li-Cor Imager model 2800. Densitometry analysis was performed using ImageJ 
analysis software (National Institutes of Health). 
 
Mito Stress Test- Isolated mitochondrial function was assessed using Seahorse XF243 
Mito Stress test as previously described (Rogers et al., 2011). Primary mouse 





RNA isolation, reverse transcription, and Real-time PCR analysis- RNA isolation 
from tissue was accomplished using TRIZOL® reagent (Invitrogen, CA) following 
manufacturer’s protocol. iScript (BioRad, CA) was used for cDNA synthesis using 1 μg 
of RNA according to manufacturer’s protocol. Real-time PCR was performed using 
CFX384TM Real Time PCR System using gene specific primers and iTaq™ Universal 
SYBR® Green Supermix (Bio-Rad, Hercules, California) for amplification measurement.  
 
Intraperitoneal glucose and insulin tolerance tests- Control diet fed male wild-type 
and knockout mice were fasted overnight (16 hours). Tail snipping was used to collect 
blood. Glucose levels were detected using One Touch Ultra Mini blood glucose meter at 
0 hour and at 30, 60, 90 and 120 minutes after intraperitoneal injection of 2.0 g/kg 
glucose or 0.05 units/kg insulin. 
 
Transmission electron microscopic imaging- Fixed tissue was rinsed with 0.1N 
Cacodylate buffer twice, 10 min each. Tissue was post-fixed in 1% osmium tetroxide 
buffered in 0.1M Cacodylate buffer for 1 hour in a fume hood. Samples were rinsed with 
distilled water 3 times, 10 min each. Samples were dehydrated in a series of graded 
ethanol as follows; 50%, 70%, 80%, 95%, 100%, 100% for 15 min each. Samples were 
placed into propylene oxide for 20 min, then into 1:1 solution of propylene oxide and 
Embed 812 resin formulation medium (Electron Microscopy sciences, Fort Washington, 
PA) overnight. The samples were then placed in fresh Embed 812 medium formula for 1 
hour. Samples were then placed into 00 size micromolds with fresh resin and placed in 
a 65-degree oven overnight. Samples were sectioned at 70nm using a Diatome 
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diamond knife on a Leica UC-7 ultra-microtome. Sections were viewed at 100kv on a 
J.E.O.L. JEM 1400 transmission electron microscope. 
 
Mitochondrial isolation- Mitochondrial isolation was performed using an established 
protocol (Chavan, et al., 2013; Krishnamurthy, et al., 2006). In brief, liver was 
homogenized in 4 ml cold isolation buffer (70 mM sucrose, 210 mM mannitol, 5 mM 
HEPES buffer, 1mM EGTA, and 0.5% fatty-acid free bovine serum albumin). 
Homogenization was achieved using a Dounce glass homogenizer at 12 strokes. 
Following two rounds of centrifugation at 800 x g for 10 min, the mitochondrial fraction 
was washed and pelleted at 8,000 x g for 10 min. The pellet was suspended in 
approximated 150 µL cold isolation buffer and either stored at -80⁰C in 50 µg aliquots or 
used immediately for extracellular flux assays.  
Primary hepatocyte isolation- Primary hepatocyte isolation and culturing were 
performed as previously described (Chavan et al., 2017). 
Mitochondria number, area and size calculations- Low magnification EM images of 
the liver samples each measured 980 µm2. A total of 12-16 images (of 980 µm2) for each 
genotype was used to calculate the average mitochondrial number. On each of these 
images, every mitochondrion was identified manually, and the perimeter was outlined with 
an optical pen using the adobe Photoshop software. The shape of each mitochondrion 
was defined by the axis ratio of the oval that best fits the area of the organelle (Adobe 
Photoshop software). Data are expressed as means ± SD. The statistical significance of 
differences was assessed with a one-or two –sample Student t test. One-Way Analysis 
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of Variance (ANOVA) was used to compare between treatment groups in the fed and 
fasted conditions. Statistically significant results from ANOVA were computed further 
using all pairwise multiple comparison procedures (Holm-Sidak method). All calculations 
were performed with SPSS statistical software package Version 22 (IBM) 
Mitochondria Respirometry- All procedures were performed with pre-chilled buffers, 
equipment, and consumables. Isolated mitochondria were re-suspended in respiration 
buffer (100 mM KCl, 10 mM KH2PO4, 5 mM MgCl2,  5 mM HEPES, 1 mM EGTA, 
0.24%BSA, pH 7.2) and kept on ice as described previously (Chao et al., 2018; Chavan, 
et al., 2017). 10 micrograms per well were loaded into Seahorse XF24 microplate in 50 
µL volume containing substrates. The loaded plate was centrifuged at 2,000 x g for 5 min 
at 4⁰C and an additional 450 µL of buffer+substrate (14 mM succinic acid and 2 mM 
rotenone) was added to each well.  
Fluorophore excitation/emission- Mitotracker red, was excited with 488 nm 25 mW 
Argon-ion laser and their emission captured through 500-550 nm band-pass filter. 
Supercomplex detection, identification, and quantification- Were performed using an 
established protocol (Jha et al., 2016). 
SC detection- 10-50 µg mitochondrial extracts were solubilized in 20 µL solubilization 
buffer (50 mM Imidazole, 500 mM 6-aminohexanoic acid, EDTA 1 mM pH7.0). 8 mg 
digitonin/mg of protein was added, and samples were incubated on ice for 30 min. 
Solubilized samples were centrifuged at maximal speed in a microcentrifuge for 30 min 
at 4⁰C. The clear supernatant was combined with 1 µL of 2.5% Coomassie G-250. 
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Samples were loaded into NativePage 3%-12% Bis – Tris gel (Invitrogen) and 
electrophoresed at 4⁰C in a Sure-Lock Xcell Tank (Invitrogen) at constant voltage of 20V 
for 60 min and 200V for 120 min or until dye front exited the gel. Simultaneous detection 
of CI-CV was achieved with the anti-OXPHOS complex kit (Mitosciences, catalog 
number, dil. 1: 2,000).  
SC identification- in total, 50 µg mitochondrial extracts (with digitonin 8 g/g protein and 
G-250 Coomassie blue) were individually loaded for the detection of each complex. After 
the transfer, the membrane was cut and incubated in the same primary antibodies used 
for western blotting. 
Blood and tissue biochemistry- Blood was drawn at the time of sacrifice via retro-orbital 
puncture, and plasma was prepared. Tissues were processed according to the kit specific 
manufacturer’s instructions. The following kits were used to determine metabolic 
parameters: triglyceride determination kit (BioVision, catalog # K622), total cholesterol kit 
(BioVision, catalog # K603), free fatty acids determination kit (BioVision, catalog # K652), 
glycogen determination kit (BioVision, catalog # K646), ketone determination kit 
(BioVision, catalog # K632).  
 
Heme measurements- Hepatic heme measurements were done using UPLC-QTOFMS 
system as described (Chavan et al., 2015).  
Statistical Analysis- Unless specified otherwise, all values presented in the text are 
mean ± standard deviation (SD). The statistical significance of differences was assessed 
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with a one-or two –sample Student t test. Where applicable, Two-Way Analysis of 
Variance (ANOVA) was used to compare between the genotypes and between the 
treatment groups. Statistically significant results from ANOVA were computed further 
using all pairwise multiple comparison procedures (Holm-Sidak method). All calculations 
were performed with SPSS (software package Version 22 IBM) and/or Sigma Plot 
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